Ian E. McCutcheon, M.D., FRCS(C), FACS

Local Presentations

1. 2025. Nuances in neurosurgery for hemangioblastomas in VHL. Invited. VHL patient-physician Meeting. Houston, TX, US.
2. 2024. Surgical Management of Pituitary Tumors. Dept of Endocrine Neoplasia and HD. Invited. Fellows Conference. Houston, Texas, US.
3. 2024. Neurofibromatosis type 1: clinical presentation and management. Invited. Clinical Neuroscience Lecture Series. Houston, Texas, US.
4. 2019. Craniotomy and reoperation for brain tumors. Conference. Together in Hope: A Conference for Brain Tumor Patients and Their Families. Houston, TX, US.
5. 2018. Ferguson SD, Suki D, McCutcheon IE: Platform Presentation: Impact of surgical resection in patients with multiple brain metastases. Conference. Joint Tumor Section Satellite Symposium. Houston, TX, US.
6. 2018. Surgery for neurofibromas and MPNSTs in neurofibromatosis type 1. Conference. Texas Neurofibromatosis Foundation Symposium. Houston, TX, US.
7. 2017. Poster/Tomczak KJ, Landers SM, Manya GC, Bolshakov S, Mulder ZA, Gardenhire EL, Yeagley MG, Ingram D, Lazar A, Wang W-L, Kukkillaya AR, McCutcheon IE, Slopis JM, Estecio MR, Rai K, Torres KE: Exploiting DNA methylation profile of NF1-associated malignant peripheral nerve sheath tumors for early diagnostics. Genomic Medicine Science Day. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
8. 2017. Poster/Kochat V, Raman AT, Landers SM, Terranova C, Ingram D, Mulder ZA, Yeagley MG, Bierd H, Wu CC, Mao X, Zhang J, Bhalla A, Tomczak KJ, McCutcheon IE, Slopis JM, Futreal A, Wang W-L, Lazar A, Rai K, Torres KE: Context-specific role of polycomb repressor complex 2 and oncogenic function of EZH2 in pathogenesis of malignant peripheral nerve sheath tumors. Genomic Medicine Science Day. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
9. 2017. Poster/Bhalla AD, Kivlin CM, Raman AT, Tomczak KJ, Watson KL, Landers SM, olshakov S, Al Sannaa GA, Slopis JM, McCutcheon IE, Lazar AJ, Torres KE: Downregulation of Cockayne syndrome B is a potential mechanism of malignant peripheral nerve sheath tumor sensitivity to poly (ADP) ribose polymerase inhibition. Genomic Medicine Science Day. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
10. 2017. Surgery and reoperation options for brain tumors. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
11. 2017. Multimodality management of pituitary carcinoma. Tran M, Fuller GN, Peñas-Prado M, Waguespack SG, Ballister L, McCutcheon IE. Conference. Baylor College of Medicine. Houston, TX, US.
12. 2016. Development of a prediction technique for tissue features in brain tumors based on radiologic-pathologic correlations. Poster: Lin J, Fuentes D, Weinberg J, Prabhu S, Ferguson S, McCutcheon IE, Fuller GN, Hazle JD, Schellingerhout D. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
13. 2015. Extent of resection in surgery for malignant glioma: how much tumor removal is enough?. Conference. Houston Neurological Society. Houston, TX, US.
14. 2015. Surgery and reoperation options for brain tumors. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
15. 2014. The added value of a 3D, heavily T2-weighted sequence for MR imaging of the brachial plexus. Amini B, Costelloe CM, Haygood TM, Kumar R, Madewell JE, McCutcheon IE, Murphy WM, Reed BJ, Slopis JM, Stafford RJ, Szklaruk J. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
16. 2014. Surgery for benign and malignant tumors of nerve in neurofibromatosis type 1. Conference. Texas NF Symposium. Houston, TX, US.
17. 2013. Surgery and reoperation options for brain tumors. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
18. 2011. VHL and the central nervous system. Conference. VHL Family Alliance Regional Meeting. Houston, TX, US.
19. 2011. Surgery and reoperation options for brain tumors. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
20. 2011. Neurosurgical procedures in the management of brain and spine metastases in renal cell carcinoma. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
21. 2010. Bedside neurosurgical procedures and craniotomy skills. Conference. Baylor College of Medicine. Houston, TX, US.
22. 2009. Endolymphatic sac tumors. Conference. VHL. Houston, TX, US.
23. 2009. Surgery and reoperation options for brain tumors. Conference. The University of Texas M.D. Anderson Cancer Center. Houston, TX, US.
24. 2009. Pituitary tumors in women: common scenarios and how to manage them. Conference. The Women's Hospital of Texas. Houston, TX, US.
25. 2008. Managing tumors affecting the central nervous system in von Hippel-Lindau disease. Conference. VHL Family Alliance. Houston, TX, US.
26. 2008. Pituitary tumors: rational medical and surgical therapy. Conference. Baylor College of Medicine. Houston, TX, US.
27. 2008. Glioma extent of resection and its impact on patient outcome/Faculty Advisor, Neurosurgery Journal Article. Conference. Baylor College of Medicine. Houston, TX, US.
28. 2008. Surgical management of pituitary tumors. Conference. The University of Texas M.D. Anderson Cancer Center. Houston, TX, US.
29. 2008. Neurological emergencies. Conference. The University of Texas M.D. Anderson Cancer Center. Houston, TX, US.
30. 2007. Neurosurgery and von Hippel-Lindau disease. Conference. VHL Family Alliance Regional. Houston, TX, US.
31. 2007. Surgery and reoperation options. Conference. The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
32. 2006. A primer of brain tumors. Conference. Texas Association of Neurological Surgeons. Houston, TX, US.
33. 2006. Stereotactic radiosurgery for spinal tumors using the CT-on-rails system. Conference. Texas Association of Neurological Surgeons. Houston, TX, US.
34. 2006. Intraoperative measurement of ACTH as a predictor of postoperative remission of Cushing's disease/Poster: Guthikonda B, Waguespack SG, McCutcheon IE. Conference. Texas Association of Neurological Surgeons. Houston, TX, US.
35. 2006. Radiographic imaging in spinal surgery. Conference. AO North America Spine. Houston, TX, US.
36. 2005. Neurosurgery for the oncologist: strategies for brain metastasis. Conference. Baylor College of Medicine. Houston, TX, US.
37. 2005. Surgery and reoperative options. Conference. The University of Texas M. D. Anderson Cancer. Houston, TX, US.
38. 2005. The brain tumors of neurofibromatosis. Conference. Houston Area Brain Tumor Network Support Group. Houston, TX, US.
39. 2004. Question-and-answer session on neurofibromatosis. Conference. Texas Neurofibromatosis Foundation. Houston, TX, US.
40. 2004. Surgical strategies in neurofibromatosis. Conference. Texas Neurofibromatosis Foundation. Houston, TX, US.
41. 2003. Surgery and reoperative options. Conference. The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
42. 2001. Brain tumor, pituitary tumors, and spine tumors. Conference. The Osler Institute. Houston, TX, US.
43. 2001. Surgery and reoperation for brain tumors. Conference. National Brain Tumor Foundation. Houston, TX, US.
44. 2000. Meningioma: the need for adjunctive therapies. Conference. Pharmacia & Upjohn. Houston, TX, US.
45. 1999. Oral board preparation: neurosurgical oncology. Conference. Osler Institute. Houston, TX, US.
46. 1997. Intracranial and pituitary tumors. Conference. American Association of Neurological Surgeons. Houston, TX, US.
47. 1997. The development of surgery for pituitary tumors. Conference. Pituitary Tumor Network Association. Houston, TX, US.
48. 1997. Case presentations: intracranial tumors. Conference. Texas Association of Neurological Surgeons/Texas Medical Association. Houston, TX, US.
49. 1997. Gonadotropin-secreting pituitary carcinoma. Conference. Texas Association of Neurological Surgeons/Texas Medical Association. Houston, TX, US.
50. 1997. Surgical treatment of glioma variants. Conference. Texas Association of Neurological Surgeons/Texas Medical Association. Houston, TX, US.
51. 1997. Advances in therapy for pituitary tumors. Conference. The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
52. 1995. Surgical management of pituitary tumors. Conference. Houston Pituitary Society/Pituitary Network Associ. Houston, TX, US.
53. 1995. Head injury: penetrating and non-penetrating injuries. Conference. Naval Reserve Center. Houston, TX, US.
54. 1995. Surgery and reoperation for brain tumors. Conference. The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
55. 1995. The biology of meningiomas. Conference. Partners in Excellence Series. Houston, TX, US.
56. 1993. The neurosurgeon's role in the management of advanced skin cancer. Conference. Partners in Excellence Series. Houston, TX, US.

Regional Presentations

1. 2011. Relief of intractable nausea after resection of brainstem hemangioblastoma: a clinical series. Conference. Texas Association of Neurological Surgeons. Dallas, TX, US.
2. 2011. Silent ACTH-producing pituitary tumor: ACTH without Cushing’s. Conference. Texas Association of Neurological Surgeons. Dallas, TX, US.
3. 2010. Difficult pituitary tumor cases: tumor in two compartments-- silent but significant (panel discussion). Conference. American Association of Clinical Endocrinologists/Texas Chapter. Dallas, TX, US.
4. 2009. Spontaneous involution of Rathke's Cleft cysts. Conference. University of Texas Southwestern School of Medicine. Dallas, TX, US.
5. 2009. Malignant gliomas: the evolving role of surgery and surgically delivered therapies. Conference. Texas Association of Neurological Surgeons. Austin, TX, US.
6. 2008. Surgical treatment in NF1 and NF2. Conference. Texas Neurofibromatosis Foundation. Irving, TX, US.
7. 2008. Innovations in pituitary surgery. Conference. Americain Association of Clinical Endocrinologists. Woodlands, TX, US.
8. 2008. Neurofibromatosis: from bench to bedside to the operating room. Conference. Denise Terrill Foundation. Dallas, TX, US.
9. 2007. Pleomorphic pineal parenchymal tumor of intermediate differentiation/Poster: Fuller GN, Grewal J, Loghin M, Debnam JM, McCutcheon IE. Conference. Society of Neuro-Oncology. Dallas, TX, US.
10. 2007. Innovations in pituitary surgery 2007. Conference. Texas Association of Neurological Surgeons. Dallas, TX, US.
11. 1999. Concurrent craniotomies for multifocal intracranial tumors. Conference. Air Force Clinical Surgeons Meeting. San Antonio, TX, US.

National Presentations

1. 2025. A tale of two challenges:  distinguishing prolactinomas from nonfunctional adenomas; and surgery for pituitary carcinomas. Invited. Duke Endocrine Grand Rounds, Virtual. Durham, North Carolina, US.
2. 2025. Hemangioblastoma:  nuances of a neurosurgical and oncological challenge. Visiting. Clinical Neuroscience Grand Rounds, Dept of Neurosurgery. New Haven, Connecticut, US.
3. 2025. Christina Abi Faraj, Ian E. McCutcheon, Maria A. Gubbiotti, Subha Perni, Maria K. Gule-Monroe, Kadir Akdemir, Victoria E. Clark, Evan D. Bander, Monica E. Loghin, Sujit S. Prabhu, Frederick F. Lang, Jeffrey S. Weinberg | Extracranial metastasis from high-grade glioma: a single-institution experience. Comparative Study of Intraoperative MRI Versus Conventional Surgery for Non-Enhancing Brain Tumors. Poster. Boston, MA, US.
4. 2025. Transsphenoidal resection of pituitary adenoma in C1-esterase inhibitor deficient patient with specific antibody deficiency:  case report. Poster. Honolulu, Hawaii, US.
5. 2025. Updates in Malignant Nerve Tumor Treatment. Invited. 9th Annual Peripheral Nerve Dissection Course - The Kline Legacy. New Orleans, LA, US.
6. 2024. Dasgupta PR, McCutcheon IE, Slopis JM: Massive thoracic meningocele in a patient with neurofibromatosis type 1. Poster. Society for Neuro-Oncology 2024 Annual Meeting. Houston, TX, US.
7. 2024. Majd NK, Kamiya-Matsuoka C, Yuan Y, Gachimova E, Wathoo C, Dagher S, Chen M, McCutcheon I, Slopis J, de Groot J: Window-of-opportunity trial of ulixertinib for MAPK-activated lower grade gliomas in adults. Poster. Society for Neuro-Oncology 2024 Annual Meeting. Houston, TX, US.
8. 2024. Landers SM, Bhalla AD, Rodriguez-Aguayo C, Keung EZ, Scally CP, Roland CL, Hunt KK, Lyu HG, Lillemoe HA, Guadagnolo A, Lazar A, McCutcheon IE, Livingston JA, Farooqi AS, Torres KE: Treatment of malignant peripheral nerve sheath tumor with bromodomain extra terminal inhibitor (BETI) in combination with radiotherapy. Poster. San Diego, CA, US.
9. 2024. Ventricular Entry, Tumor Contiguity, and Leptomeningeal Disease after Resection of Supratentorial Glioblastoma. Invited. American Academy of Neurological Surgery 2024 Annual Meeting. Half Moon Bay, CA, US.
10. 2024. Abi Faraj C, Suki D, Lin H, Ene CI, Weinberg JS, McCutcheon IE, Prabhu SS, DeMonte F, North RY, Kim BYS, Ferguson SD, Lang FF Jr: Conventional surgical resection versus stereotactic radiosurgery for 1-3 cm singles brain metastases. Poster. Houston, TX, US.
11. 2024. Munnangi P, Gingrich A, Chiang Y-J, Lyu H, Lillemoe H, Scally C, Keung E, Roland C, Hunt K, Slopis J, McCutcheon IE, Torres K: Impact of demographics and socioeconomic factors on likelihood of receiving surgery for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumors (MPNST). Poster. San Francisco, CA, US.
12. 2024. Surgical treatment of pituitary carcinoma: long-term outcomes in a single-institution experience. Invited. Society of University Neurosurgeons 2024 Annual Meeting. Adelaide, AU.
13. 2024. Gubbiotti MA, Aldape K, Quezado M, Abdullaev Z, Huse JT, McCutcheon IE, Weathers S-P, Schomer D, Puduvalli V, Ballester LY: An institutional experience of methylation profiling of unusual historical cases: solving mysteries up to 46 years after initial diagnosis. Poster. Olympic Valley, CA, US.
14. 2024. Stitzlein LM, Sun YY, Munir F, McCutcheon IE, Slopis JM, Zaky W: Clinical characteristics and therapeutic interventions in a case series of pediatric patients with vestibular schwannomas and neurofibromatosis type 2. Poster. Philadelphia, PA, US.
15. 2024. Abi Faraj C, Tran M, Ferguson SD, Fuller GN, Majd N, Waguespack SG, McCutcheon IE: Surgical management and long-term outcomes in pituitary carcinoma: a single-institution experience. Poster. American Association of Neurological Surgeons 2024 Annual Meeting. Chicago, IL, US.
16. 2024. Beckham TH, Yeboa DN, Kudchadker RJ, Tom MC, Li J, Perni S, Swanson TA, Ferguson SD, Prabhu SS, McCutcheon IE, Ying Y, Lang FF, Heather L, Ene C, McAleer MF, Weinberg JS. Gammatile vs. postoperative stereotactic radiosurgery for radiotherapy-naïve brain metastases: trial in progress. Poster. Chicago, IL, US.
17. 2024. Abi Faraj C, Moss N, Leung CH, Gule-Monroe MK, Suki D, Gubbiotti M, Prabhu S, Ferguson SD, Heimberger A, Rao G, McCutcheon IE, Sawaya R, Lang FF, Weinberg JS: Utility of postoperative CT scan following stereotactic brain biopsy. Poster. Chicago, IL, US.
18. 2024. Abi Faraj C, Hasanov M, Suki D, Katlowitz K, Srinivasan S, Goethe EA, Prabhu S, Weinberg JS, McCutcheon IE, Glitza Oliva IC, Ferguson SD: Factors associated with overall survival and 90-day mortality following resection of melanoma brain metastases (MBMs). Poster. Chicago, IL, US.
19. 2024. Abi Faraj C, Garber ST, Lin H, Prashant Prasad G, Suki D, Waguespack SG, Habra M, McCutcheon IE: Distinguishing prolactinoma from nonfunctioning pituitary adenoma with hyperprolactinemia by clinical, laboratory, and imaging characteristics. Poster. American Association of Neurological Surgeons 2024 Annual Meeting. Chicago, IL, US.
20. 2024. Beckham TH, Didzinski SO, Pasli M, Perni S, Tom MC, Ghia AJ, Yeboa DN, McAleer MF, Swandon TA, McGovern SL, Wang C, Chung C, Briere TM, An R, De BS, Jiang W, Glitza IC, Kim B, McCutcheon IE, Li J: Radiosurgery for five or more brain metastases in the era of systemic therapy. American Society of Clinical Oncology. Poster. Chicago, IL, US.
21. 2024. Hasanov M, Milton D, Srinivasan S, Abi Faraj C, McCutcheon IE, Glitza Oliva IC, Ferguson SD: Clinical factors associated with leptomeningeal disease (LMD) in patients diagnosed with melanoma brain metastasis (MBM). Poster. American Association of Neurological Surgeons 2024 Annual Meeting. Chicago, IL, US.
22. 2024. Goethe EA, Zakaria R, Suki D, Srinivasan S, Prabhu S, Weinberg JS, McCutcheon IE, Ferguson SD: Surgical outcome of motor region brain metastases: a single-institution experience. American Association of Neurological Surgeons. Poster. Chicago, IL, US.
23. 2024. Neoadjuvant therapy for malignant peripheral nerve sheath tumors: yes or no?. Invited. Chicago, IL, US.
24. 2024. Gingrich AA, Landers S, Bhalla A, Rodriguez-Aguayo C, Lazcano R, Satpati S, Lebron-Torres A, Keung EZ, Scally CP, Roland CL, Hunt KK, Lyu H, Lillemoe H, Guadagnolo A, Lazar A, Slopis JM, McCutcheon IE, Livingston JA, Farooqi A, Rai K, Torres KE: Role of bromodomain extra terminal inhibitor (BETi) in combination with radiotherapy for the treatment of NF1-associated malignant peripheral nerve sheath tumors. Poster. San Diego, CA, US.
25. 2024. Torres KE, Munnangi P, Montgomery AE, Gingrich A, Landers S, Wangsiricharoen S, Bhalla A, Lin PP, Lewis VO, Moon BS, Patel S, Scally C, Keung EZ, Roland CL, Hunt KK, McCutcheon IE, Bird JE, Yu W, Eberlin LS: Use of the MasSpec Pen technology for accurate determination of surgical margins of myxofibrosarcomas (MFS). Poster. Atlanta, GA, US.
26. 2024. Torres KE, Montgomery AE, Munnangi P, Gingrich A, Landers S, Wangsiricharoen S, Bhalla A, Lin PP, Lewis VO, Moon BS, Shreyaskumar S, Lyu H, Scally C, Keung EZ, Roland CL, Hunt KK, McCutcheon IE, Bird JE, Yu W, Eberlin LS: Use of the MasSpec Pen technology for accurate determination of sarcomas and surgical margin assessment. Poster. Atlanta, GA, US.
27. 2024. Gingrich A, Montgomery AE, Munnangi P, Landers S, Bhalla A, Lin PP, Lewis VO, Moon BS, Patel S, Lyu H, Lillemoe H, Scally C, Keung EZ, Roland CL, Hunt KK, McCutcheon IE, Bird JE, Yu W, Eberlin LS, Torres KE: Evaluation of the MasSpec Pen technology for molecular identification of MPNST and surgical margin assessment. Poster. Atlanta, GA, US.
28. 2024. Panel Disscussion, Texas Association of Neurological Surgeons, “Brain metastases: updates on neurosurgical management”. Invited. Panel Disscussion, Texas Association of Neurological Surgeons, “Brain metastases: updates on neurosurgical management”. Corpus Christi, TX, US.
29. 2024. Speaker, New Orleans Peripheral Nerve Dissection Course: The Kline Legacy, Louisiana State University Medical Center, “Nerve sheath tumors: clinical nuances and techniques.”. Invited. Speaker, New Orleans Peripheral Nerve Dissection Course: The Kline Legacy, Louisiana State University Medical Center, “Nerve sheath tumors: clinical nuances and techniques.”. New Orleans, LA, US.
30. 2024. Neurosurgical Residency Program. Visiting. Fairfax, Virginia, US.
31. 2021. Landry J, Kochat V, Landers SM, Bhalla AD, Lazcano R, Parker LA, Miller TM, Ingram D, Wiener D, Davis B, Boudreau B, Wang W-L, Keung EZ, Scally C, Roland CL, Hunt KK, Feig BW, Slopis JM, McCutcheon IE, Wilson-Robles H, Lazar AJ, Rai K, Wustefeld-Janssens B, Torres KE: Comparative review of human and canine peripheral nerve sheath tumors. Conference. Virtual Meeting, Connective Tissue Oncology Society, Annual Meeting, US.
32. 2021. Haider AS, Ene CI, Fuller GM, Schomer DF, Gule-Monroe M, DeMonte F, Ferguson SD, Lang FF, McCutcheon IE, Prabhu SS, Raza SM, Suki D, Weinberg JS, Sawaya R: Fourth ventricle subependymoma: to operate or not to operate?. Conference. Congress of Neurological Surgeons, Annual Meeting. Austin, TX, US.
33. 2021. Ott M, Kassab C, Zamler D, Gupta P, Srinivasan V, Rao G, Prabhu SS, Huse J, Fuller GN, McCutcheon IE, Sawaya R, Lang FF, Ferguson SD, Weinberg JS, Phat KP, Freiberg B, Burks J, Heimberger AB: Differences in the immune cell interactome between gliomas and brain metastasis based on STAT3 expression. Invited. Virtual Meeting, American Association for Cancer Research, Annual Meeting, US.
34. 2020. Efficacy of pembrolizumab in patients with pituitary carcinoma: results from a phase II study. Conference. [Virtual] Society for Neuro-Oncology. Austin, TX, US.
35. 2020. Pseudotumor from meningiomatosis in neurofibromatosis type 2. Conference. [Virtual] Society for Neuro-Oncology. Austin, TX, US.
36. 2020. Comparative study of human and canine peripheral nerve sheath tumors (PNST): morphology, prognosis, treatment, and epigenetics. Conference. [Virtual] 2nd Annual Paws for a Cure Research Symposium, US.
37. 2020. Nerve sheath tumors. Invited. 6th Annual Peripheral Nerve Dissection Course – The Kline Legacy in New Orleans. New Orleans, LA, US.
38. 2019. Surgical strategies for controlling tumors in neurofibromatosis type 1. Invited. Texas Neurofibromatosis Foundation Symposium. San Antonio, TX, US.
39. 2019. Agosto S, Waguespack S, Cote G, Hess K, Habra M, Jimenez C, Hu M, Sherman SI, Busaidy N, Dadu R, Tatsui C, McCutcheon IE, Grubbs E, Williams, M, Shah K, Cabanillas M: Brain metastases in thyroid cancer: molecular profile and institutional experience of a single tertiary referral center in the era of kinase inhibitor therapy. Conference. The Endocrine Society. New Orleans, LA, US.
40. 2019. Landry JP, Watson KL, Chiang YJ, Keung EZ, Feig BW, Hunt KK, Roland CL, Cormier JN, Lazar AE, Slopis JM, McCutcheon IE, Torres KE: Cancer risk in patients with neurofibromatosis type 1. Conference. Society of Surgical Oncology. San Diego, CA, US.
41. 2019. Nerve Sheath Tumors, LSU Neurosurgery Peripheral Nerve Dissection Course - The Kline Legacy. Invited. Nerve Sheath Tumors, LSU Neurosurgery Peripheral Nerve Dissection Course - The Kline Legacy. New Orleans, LA, US.
42. 2018. Ott M, Zhou S, Wei J, de Groot J, Huse J, Fuller G, McCutcheon IE, Prabhu S, Ferguson S, Weinberg J, Sawaya R, Rao G, Lang F, Heimberger AB. Poster: Glioma immune profiling reveals unique immune therapeutic opportunities. Conference. Society for Neuro-Oncology. New Orleans, LA, US.
43. 2018. McCutcheon IE, Ferguson SD, Glitza IC: Predictors of survival in patients with leptomeningeal dissemination from metastatic melanoma. Invited. American Academy of Neurological Surgery. Palm Beach, FL, US.
44. 2018. Edward H. Oldfield, M.D. Memorial Symposium, “From prolactinomas to pituitary carcinomas: adventures in pituitary surgery at the M. D. Anderson Cancer Center. Invited. National Institutes of Health. Bethesda, MD, US.
45. 2018. Neurosurgical management of von Hippel-Lindau disease: dilemmas and solutions. Invited. Mayo Clinic Jacksonville, Neurosurgery/Neuroscience Grand Rounds. Jacksonville, FL, US.
46. 2018. Wagner K, Gressot LV, McCutcheon IE: Poster: Acute intracranial hemorrhage is associated with poor outcomes in cancer patients with bleeding disorder. Invited. American Association of Neurological Surgeons. New Orleans, LA, US.
47. 2018. Cushing’s disease: diagnostic and surgical pitfalls, Practical Clinic on Practical and Technical Aspects of Transsphenoidal Surgery. Invited. American Association of Neurological Surgeons. New Orleans, LA, US.
48. 2018. Von Hippel-Lindau disease and the neurosurgeon: developing rational surgical and medical therapy for hemangioblastomas. Invited. Moffitt Cancer Center, Department of Neuro-Oncology Grand Rounds. Tampa, FL, US.
49. 2018. Kochat V, Raman AT, Landers SM, Terranova C, Wu CC, Mao X, Ingram D, Mulder ZA, Yeagley MG, Bierd H, Bhalla A, McCutcheon IE, Slopis J, Futreal A, Lang W-L, Lazar L, Rai K, Torres KE: POSTER: Non-canonical role of EZH2 in the pathogenesis of malignant peripheral nerve sheath tumors with functionally inactive polycomb repressor complex 2. Invited. Keystone Symposium on Cancer Epigenetics: New Mechanisms, New Therapies. Keystone, CO, US.
50. 2018. Tumors of peripheral nerve. Invited. New Orleans Peripheral Nerve Dissection Course: The Kline Legacy. New Orleans, LA, US.
51. 2017. Mahajan A, Wang X, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown PD, Prabhu SS, Lang FF, McGovern S, McCutcheon IE, Sulman E, Heimberger A, Ferguson S, Ghia A, Guha-Thakurta N, Sawaya R, Rao G: Poster: Local recurrence pattern of patients enrolled on a randomized study of post-operative stereotactic radiosurgery vs. observation for completely resected brain metastasis. Invited. Society of Neuro-Oncology. San Francisco, CA, US.
52. 2017. Effendi S, Webb S, Prall A, McCutcheon IE: Acute stroke care system. Council of State Neurosurgical Societies, Congress of Neurological Surgeons. Conference. Effendi S, Webb S, Prall A, McCutcheon IE: Acute stroke care system. Council of State Neurosurgical Societies, Congress of Neurological Surgeons. Boston, MA, US.
53. 2017. Pituitary carcinoma. 79th Annual Meeting of the American Academy of Neurological Surgery, Jointly sponsored by the American Association of Neurological Surgeons. Invited. Pituitary carcinoma. 79th Annual Meeting of the American Academy of Neurological Surgery, Jointly sponsored by the American Association of Neurological Surgeons. Santa Barbara, CA, US.
54. 2017. Endocrine consequences of pituitary surgery and their management/Practical Clinic on Practical and Technical Aspects of Transsphenoidal Surgery. Invited. American Association of Neurological Surgeons. Los Angeles, CA, US.
55. 2017. Peripheral nerve tumors: surgical principles and nuances. Invited. New Orleans Peripheral Nerve Dissection Course: The Kline Legacy. New Orleans, LA, US.
56. 2016. Leptomeningeal disease (LMD) from metastatic melanoma: a single institution experience and predictors of survival. Bindal S, Ferguson SD, Davies MA, Haydu L, Bassett RL Jr, McCutcheon IE, Glitza IC: Poster. Conference. Society for Melanoma Research. Boston, MA, US.
57. 2016. Radiosurgery for invasive pituitary adenomas and pituitary carcinoma. Conference. 7th Meeting of the Asian Gamma Knife Academy. Honolulu, HI, US.
58. 2016. Adjuvant radiosurgery vs. observation after resection of brain metastasis: which is better?. Invited. 7th Meeting of the Asian Gamma Knife Academy. Honolulu, HI, US.
59. 2016. Intracranial bleeding in neurosurgical oncology. Conference. Practical Course: Neurocritical Care and Neurosurgical Emergencies Update, Congress of Neurological Surgeons Annual Meeting. San Diego, CA, US.
60. 2016. Distinguishing prolactinomas from nonfunctional pituitary adenomas with hyperprolactinemia by clinical, laboratory, and imaging characteristics: multivariate analysis and creation of a predictive nomogram. Invited. American Academy of Neurological Surgery. Jackson Hole, WY, US.
61. 2016. Post-operative stereotactic radiosurgery vs. observation for completely resected brain metastases: results of a prospective randomized trial. Platform presentation: Mahajan A, Ahmed S, Li J, McAleer MF, Weinberg J, Brown PD, Lang FF, McGovern SL, McCutcheon IE, Heimberger A, Sulman EP, Ghia AJ, Ferguson S, Hess K, Rao G. Conference. American Society of Therapeutic Radiation Oncology. Boston, MA, US.
62. 2016. Neurosurgery for VHL: when and where to operate. Conference. VHL Alliance Annual Family Meeting. Los Angeles, CA, US.
63. 2016. The surgical treatment of metastatic spine tumors within the intramedullary compartment. Poster: Strickland BA, Chakrabarti I, McCutcheon IE, Rhines LD, Weinberg JS. Conference. American Association of Neurological Surgeons. Chicago, IL, US.
64. 2016. Patterns of recurrence and survival in sporadic, neurofibromatosis type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. Conference. Society of University Neurosurgeons. Scottsdale, AZ, US.
65. 2016. Pilot study of dovitinib in patients with von Hippel-Lindau disease. Pilié PG, Matin S, Woodson AH, Marcott VD, Bird SM, Slack RS, Fuller GN, McCutcheon IE, Jonasch E. Conference. Genitourinary Cancers Symposium. San Francisco, CA, US.
66. 2016. Surgical principles of peripheral nerve tumors. 183.New Orleans Peripheral Nerve Dissection Course: The Kline Legacy. Invited. New Orleans Peripheral Nerve Dissection Course. New Orleans, LA, US.
67. 2015. Therapeutic outcomes of intrathecal interleukin-2 in metastatic melanoma patients with leptomeningeal disease (LMD)/Poster: Glitza IC. Rohlfs M, Bassett R, John I, Richard J, Iqbal M, Bernzen T, Gerber D, Lacey C, Diab A, Amaria R, Woodman SE, Patel S, Yee C, Hwu W-J, McCutcheon IE, Heimberger AE, Hwu P, Papadopoulous N, Davies MA. Conference. Society of Neuro-Oncology. San Antonio, TX, US.
68. 2015. Anesthetic management of juvenile amyotrophic lateral sclerosis (ALS) for MRI and spinal cord injection of stem cells/Poster: Arunkumar R, Bhavsar S, McCutcheon IE. Conference. American Society of Anesthesiologists. San Diego, CA, US.
69. 2015. Intracranial bleeding in neurosurgical oncology/Practical Course: Neurocritical Care and Neurosurgical Emergencies Update. Conference. Congress of Neurological Surgeons 2015 Annual Meeting. New Orleans, LA, US.
70. 2015. Practical pituitary physiology. Practical Clinic on Practical and Technical Aspects of Transsphenoidal Surgery. Invited. American Association of Neurological Surgeons. Washington, DC, US.
71. 2015. Autologous stem cell transplantation to spinal cord for juvenile amyotrophic lateral sclerosis.Worth LL, McCutcheon IE, Koenig MK, Slopis JM, Champlin RE. Conference. Autologous stem cell transplantation to spinal cord for juvenile amyotrophic lateral sclerosis.Worth LL, McCutcheon IE, Koenig MK, Slopis JM, Champlin RE. San Diego, CA, US.
72. 2014. Neoadjuvant radiosurgery for brain metastasis: Pro. Controversies II. Invited. Congress of Neurological Surgeons 2014 Annual Meeting. Boston, MA, US.
73. 2014. Intracranial bleeding in neurosurgical oncology. Practical Course: Neurocritical Care and Neurosurgical Emergencies Update. Invited. Congress of Neurological Surgeons 2014 Annual Meeting. Boston, MA, US.
74. 2014. Emerging immunohistochemical markers for malignant peripheral nerve sheath tumor (MPNST). Authors: Al Sannaa GA, Ingram D, Torres KE, Wang W-L, McCutcheon IE, Lazar AJ. Conference. College of American Pathologists. Chicago, IL, US.
75. 2014. Sarcomatous brain metastases: a single institution 28 years of experience. Authors: Al Sannaa GA, Wang W-L, McCutcheon IE, Lazar AJ. Conference. College of American Pathologists. Chicago, IL, US.
76. 2014. The surgical treatment of pituitary carcinoma: the M. D. Anderson experience. Invited. Society of University Neurosurgeons. Seattle, WA, US.
77. 2014. A novel combination therapy for the treatment of malignant peripheral nerve sheath tumors. Poster:Kivlin CM, Ma XY, Ingram D, Al Sannaa GA, May CD, Bolshakov S, Garnett J, Landers S, McCutcheon IE, Slopis J, Lev D, Lazar AJ, Torres KE. Conference. Children’s Tumor Foundation. Washington, DC, US.
78. 2014. Identification of molecular drivers of human hemangioblastoma. Poster: Sun M, Monzon F, Zhou L, Liu X, Zhiyong Ding, Xuesong Zhang X, Bai S, German P, Kalra S, Tannir N, Matin S, Fuller F, McCutcheon I, Jonasch E. Conference. American Association of Cancer Research. San Diego, CA, US.
79. 2013. BMN 673, a novel potent PARP inhibitor for the treatment of malignant peripheral nerve sheath tumor (MPNST)/ Poster: Kivlin CM, Ma XY, Ingram D, Al Sannaa GA, Feng Y, Bolshakov S, McCutcheon IE, Slopis JM, Lev D, Lazar AJ, Torres KE. Conference. Connective Tissue Oncology Society. New York, NY, US.
80. 2013. Downregulation of ERCC6 is a potential mechanism for the effect of PARP inhibition in malignant peripheral nerve sheath tumor (MPNST)/Poster: Kivlin CM, Ma XY, Zhu QS, Belousov R, Ingram D, Al Sannaa GA, May C, Garnett J, Bolshakov S, McCutcheon IE, Slopis JM, Lev D, Lazar AJ, Torres KE. Conference. Connective Tissue Oncology Society. New York, NY, US.
81. 2013. A clinicopathologic portrait of sporadic peripheral schwannomas/Poster: Young ED, Ingram D, Metcalf-Doetsch W, Khan D, Le Loarer F, Lazar AJ, McCutcheon IE, Slopis JM, Torres KE, Pollock RE, Lev DC. Conference. Connective Tissue Oncology Society. New York, NY, US.
82. 2013. Practical Course: Neurocritical Care and Neurosurgical Emergencies Update, Intracranial bleeding in neurosurgical oncology. Conference. Congress of Neurological Surgeons. San Francisco, CA, US.
83. 2013. The impact of neurofibromatosis type 1 status on patient outcome in malignant peripheral nerve sheath tumors/Poster: Al Sannaa G, McCutcheon IE, Slopis JM, Zou C, Lev D, Pollock RE, Torres KE, Lazar AJ. Conference. Connective Tissue Oncology Society. New York, NY, US.
84. 2013. VHL and the central nervous system (panel discussion). Conference. VHL Family Alliance Annual Meeting. Ann Harbor, MI, US.
85. 2013. Endolymphatic sac tumors: detection and treatment. Conference. VHL Family Alliance Annual Meeting. Ann Harbor, MI, US.
86. 2013. Pituitary endocrinology before and after surgery/Practical Clinic on Practical and Technical Aspects of Transsphenoidal Surgery. Conference. American Association of Neurological Surgeons. New Orleans, LA, US.
87. 2012. Multivariate predictors of IDH1 status in malignant astrocytoma/Poster: Barker FG, Cahill DP, Aldape K, Sawaya R, Lang FF, Prabhu SS, Weinberg JS, McCutcheon IE, Rao G. Invited. Society of Neuro-Oncology. Washington, DC, US.
88. 2012. Outcomes after surgery and radiotherapy for spinal myxopapillary ependymoma: update of the M D Anderson Cancer Center experience/Poster: Wang Y, Li J, Allen PK, Mahajan A, McCutcheon IE, Maor MH, Chang EL, Brown PD. Invited. American Society of Therapeutic Radiology and Oncology. Boston, MA, US.
89. 2012. Prolonged survival in patients undergoing aggressive surgery for IDH1-mutant malignant astrocytoma/Platform presentation: Cahill DP, Barker FG, Suki D, Prabhu SS, Weinberg J, Lang FF, Rao G, McCutcheon IE, Sawaya R. Invited. American Academy of Neurological Surgery. Chatham, MA, US.
90. 2012. Treating Cushing’s disease with surgery: ways of achieving a cure. Invited. The Magic Foundation 7th Annual Conference. Chicago, IL, US.
91. 2012. Re-irradiation for pituitary adenomas/Platform: Verma J, Waguespack SG, McCutcheon IE, Mahajan A. Invited. American Radium Society. Las Vegas, NV, US.
92. 2012. Ommaya reservoir placement in the pediatric population/Poster: Mayer RR, Hwang SW, Jea A, Debnam JM, Dauser RC, Groves MD, McCutcheon IE, Sawaya R, Weinberg JS. Invited. American Association of Neurological Surgeons. Miamo, FL, US.
93. 2012. A prospective randomized trial of seizure prophylaxis in patients undergoing surgery for supratentorial intraparenchymal tumors/Platform Presentation: Lang FF, Wu A, Trinh V, Suki D, Hess K, Weinberg J, McCutcheon I, Prabhu S, Heimberger A, Sawaya R. Invited. American Association of Neurological Surgeons. Miami, FL, US.
94. 2012. Subcortical injury is an independent predictor of worsening neurological deficits following awake craniotomy procedures/Poster: Trinh VT, Fahim DK, Shah K, McCutcheon I, Suki D, Sawaya R, Prabhu SS. Invited. American Association of Neurological Surgeons. Miami, FL, US.
95. 2012. Pituitary endocrinology before and after surgery/Practical Clinic on Practical and Technical Aspects of Transsphenoidal Surgery. Invited. American Association of Neurological Surgeons. Miami, FL, US.
96. 2012. Ventriculoperitoneal shunting using on-off valves in patients with leptomeningeal metastases and intracranial hypertension. Conference. Society of University Neurosurgeons. Atlanta, GA, US.
97. 2011. New approaches to Rathke’s cleft cysts/Luncheon seminar on What’s New in Pituitary Surgery. Invited. Congress of Neurological Surgeons. Washington, DC, US.
98. 2011. Scalp tumors with cranial extension in 60 patients: multidisciplinary surgical strategies and outcomes/Platform Presentation: Mayer RR, Fahim DK, Mohan K, Sacks JM, Rao G, Adelman DM, McCutcheon IE. Invited. Congress of Neurological Surgeons. Washington, DC, US.
99. 2011. Complications and risk factor analysis of Ommaya reservoir placement in 835 patients/Platform Presentation: Mayer RR, Suki D, Debnam J, Kitagawa RS, McCutcheon IE, Groves MD, Sawaya R, Weinberg JS. Invited. Congress of Neurological Surgeons. Washington, DC, US.
100. 2011. Low-dose, stand overnight and low dose dexamethasone suppression test in patients with mild and/or episodic hypercortisolism/Poster: Shayesteh N, Mangubat M, Haykani M, Lee ML, McCutcheon IE, Friedman TC. Invited. ENDO. Boston, MA, US.
101. 2011. Orbital reconstruction of NF1-associated dysplasia of sphenoid wing using a synthetic clamshell prosthesis/Poster: McCutcheon IE, Slopis JM, Esmaeli B, Skoracki RJ. Invited. Children’s Tumor Foundation NF Conference. Jackson Hole, WY, US.
102. 2011. Surgery for gliomas adjacent to motor cortex and factors influencing surgical management in 365 cases/Platform Presentation:Prabhu SS, Abuelem T, Suki D, McCutcheon IE, Weinberg J, Lang FF, DeMonte F, Sawaya R. Invited. American Association of Neurological Surgeons. Denver, CO, US.
103. 2011. Endocrine evaluation and treatment of pituitary tumors. Invited. American Association of Neurological Surgeons. Denver, CO, US.
104. 2011. Relief of intractable nausea after resection of brainstem hemangioblastoma in patients with von Hippel-Lindau disease: a clinical series/Poster: McCutcheon IE, Viswanathan A, Jonasch E. Invited. American Association of Neurological Surgeons. Denver, CO, US.
105. 2010. Phospho-histone H3 (PHH3) immunoreactivity in non-functioning pituitary adenomas/Poster: Hightower E, Devin J, Fuller G, Corley L, McCutcheon IE, Waguespack SG, Shah K, Hess K, Cabanillas ME. Invited. ENDO. San Deigo, CA, US.
106. 2010. Post-operative day 3 cortisol as a predictor of HPA axis integrity after transsphenoidal surgery/Poster: Khan MI, McCutcheon IE, Nogueras-Gonzalez GM, Munsell MF, Devin JK, Jimenez C, Habra MA, Levine NB, Waguespack SG. Invited. ENDO. San Deigo, CA, US.
107. 2010. Papillary thyroid cancer with undetectable thyroglobulin and metastases to pituitary gland and spleen/Poster: Michaelis CL, McCutcheon IE, Sherman SI. Invited. ENDO. San Deigo, CA, US.
108. 2010. Evaluation of CSF flow by whole-body scintigraphy/Poster: Wong FCL, McCutcheon IE. Invited. Society of Nuclear Medicine. Salt Lake City, UT, US.
109. 2010. Pheochromocytomas and Cushing’s disease: a rare combination with unclear etiology/Poster: Barrera T, Rich T, Perrier ND, McCutcheon IE, Jimenez C, Habra MA. Invited. ENDO. San Deigo, CA, US.
110. 2010. Cortical mapping of leg function using tibial SSEP in patients with paracentral tumors/Poster: Fahim D, Hauck E, Prabhu SS, Tummula S, McCutcheon IE. Invited. Association of Neurological Surgeons. Philadelphia, PA, US.
111. 2010. Endocrine evaluation before pituitary surgery. Invited. American Association of Neurological Surgeons. Philadelphia, PA, US.
112. 2010. Open commissural myelotomy for controlling tumor-induced pelvic or thoracic pain/Poster: Viswanathan A, Burton AW, Abuelem T, McCutcheon IE. Invited. American Association of Neurological Surgeons. Philadelphia, PA, US.
113. 2009. Cyclic sciatica from extrapelvic endometriosis affecting sciatic nerve/Poster: Floyd JR III, Keeler EW, Euscher ED, McCutcheon IE. Invited. Congress of Neurological Surgeons. New Orleans, LA, US.
114. 2009. Indications and technique for enhanced prolactinoma resection. Invited. Congress of Neurological Surgeons. New Orleans, LA, US.
115. 2009. An association between Notch1 and prognosis in glioblastoma/Poster: Wu AS, Cheung H, Cote GJ, Fuller GN, Suki D, McCutcheon IE. Invited. Joint meeting of the Society for Neuro-Oncology and the AANS/CNS Section on Tumors. New Orleans, LA, US.
116. 2009. Prognostic factors influencing the outcome of 55 consecutive patients undergoing surgery for metastatic melanoma to the spine/Poster:Tatsui CE, Chern JJ, St. Clair EG, McCutcheon IE, Rhines LD. Invited. Congress of Neurological Surgeons. New Orleans, LA, US.
117. 2009. Gliosarcoma vs. glioblastoma: a case-control study of clinical outcomes/Poster: Kitagawa R, Suki D, Fuller GN, Sloan AE, McCutcheon IE. Invited. Congress of Neurological Surgeons. New Orleans, LA, US.
118. 2009. Intraoperative mapping of cortical leg representation using somatosensory evoked potentials from posterior tibial nerve/Poster: Fahim D, Hauck E, Prabhu SS, Tummula S, McCutcheon IE. Conference. Congress of Neurological Surgeons. New Orleans, LA, US.
119. 2009. DuraSealTM spinal sealant as an adjunct to sutured dural repair in the spine: results of a prospective, multi-center, randomized controlled study/Oral Presentation: Wright NM, Kim KD, Cosgrove R, Tew JM Jr, Kaiser MG, McCormick PC, Chestnut R, Ellenbogen RG, Van Loveren HR, Vale FL, Shaffrey ME, Chen TC, Wang MY, Mayberg MR, Sharan AD, Gerszten PC, Welch WC, Graham RS, Brown FD, Fessler RG, Deutsch H, Shah MV, McCutcheon IE, Karahalios DG, Long DM, Hopkins LN III, Jallo J, Delashaw JB, Ondra SL, Gross RE. Invited. Congress of Neurological Surgeons. New Orleans, LA, US.
120. 2009. Dual targeting of AKT and mTOR: a potential therapeutic approach for malignant peripheral nerve sheath tumor/Poster: Slopis JM, McCutcheon IE, Zou CY, Smith KD, Shu QS, Liu J, Meric-Bernstam F, Bornman WG, Mills G, Lazar AJ, Pollock RE, Lev D. Conference. Children's Tumor Foundation NF Conference. Portland, OR, US.
121. 2009. Apparently sporadic pituitary tumors presenting in children and young adults are rarely caused by mutations in the MEN1 gene/Poster: Waguespack SG, McCutcheon IE, Devin JK, Evans DB, Cote G, Rich T. Conference. The Endocrine Society. Washington, DC, US.
122. 2009. Clinical, pathological and molecular variables predictive of malignant peripheral nerve sheath tumor (MPNST) outcome/McCutcheon IE, Slopis JM, Zou CY, Smith KD, Liu J, Lahat G, Myers S, Wang WL, Zhang W, Lazar AJ, Pollock RE, Lev D. Invited. Children's Tumor Foundation. Portland, OR, US.
123. 2009. Treatment of VHL patients with sunitinib: clinical observations and translational studies/Poster: Matin S, McCutcheon IE, Gombos D, Waguespack S, Wen S, Zhang Y, Davis D, Smith L, Fuller G, Jonasch E. Conference. American Society for Clinical Oncology. Orlando, FL, US.
124. 2009. Endocrine evaluation before pituitary surgery/Pracitical Clinic on Practical and Technical Aspects of Transsphenoidal Surgery. Invited. American Association of Neurological Surgeons. San Francisco, CA, US.
125. 2009. Surgical treatment of intrinsic tumors of the sciatic nerve/Kitagawa R, Slopis JM, Tummala S, Lin V, Smitherman S, McCutcheon IE. Invited. American Association of Neurological Surgeons. San Diego, CA, US.
126. 2009. Beyond pituitary surgery: radiosurgery vs. adrenalectomy when Cushing's disease persists or recurs. Invited. 4th Annual Convention for Adults with Endocrine Disorders. Las Vegas, NV, US.
127. 2009. Treating Cushing's disease with surgery: ways of achieving a cure. Invited. 4th Annual Convention for Adults with Endocrine Disorders. Las Vegas, NV, US.
128. 2008. Ventriculoperitoneal shunting using on-off valves in patients with leptomeningeal metastases and intracranial hypertension/Poster: Bogitch R, McCutcheon IE, Rao G, Prabhu SS, Groves MD. Conference. Society of Neuro-Oncology. Lake Las Vegas, NV, US.
129. 2008. Evaluation of cerebrospinal fluid (CSF) flow by whole-body scintigraphy/Poster: Wong F, Kim EE, Groves MD, McCutcheon IE, Zhuang M, Podoloff D. Conference. Radiological Society of North America. Chicago, IL, US.
130. 2008. Prognostic relevance of the status of systemic metastasis in 200 consecutive patients undergoing surgery for metastatic renal cell carcinoma of the spine/Poster: Tatsui CE, Kim SS, Habotiglu M, McCutcheon IE, Smitherman S, Suki D, Salaskar A, Rhines LD. Conference. Congress of Neurological Surgeons. Orlando, FL, US.
131. 2008. Cryocoagulation prior to resection of vascular tumors of the spine and brain: a method for minimizing blood loss/Poster: Almodovar LJ, Tatsui CE, Prabhu SS, McCutcheon IE. Conference. Congress of Neurological Surgeons. Orlando, FL, US.
132. 2008. Endocrine evaluation and treatment of pituitary tumors/Practical Clinic on Practical and Technical Aspects of Transsphenoidal Surgery. Conference. American Association of Neurological Surgeons. San Francisco, CA, US.
133. 2008. The association of meningioma and breast cancer in men/Poster: Rao G, Lui J, Giordano S, McCutcheon IE. Conference. American Association of Neurological Surgeons. Chicago, IL, US.
134. 2007. Surgical outcomes of multiple brain metastases: analysis of 202 patients/Poster: Lovo EE, Suki D, Lang F, McCutcheon IE, Hassenbusch SJ, Sawaya R, Prabhu SS. Conference. Congress of Neurological Surgeons. San Diego, CA, US.
135. 2007. MDCT evaluation of the spine in patients with neurofibromatosis type 1/Poster: Debnam JM, Ketonen L, Slopis JM, McCutcheon IE, Hamberg LM, Hunter GJ. Conference. American Society of Neuroradiology. Chicago, IL, US.
136. 2007. Surgical treatment of nerve sheath tumors involving the sciatic nerve in NF1/Poster: McCutcheon IE, Kitagawa R, Tummala S, Lin V, Slopis JM. Conference. Neurofibromatosis Consortium Conference: Models, Mechanisms, and Therapeutic Targets. Park City, UT, US.
137. 2007. Rosai-Dorfman disease affecting the sella/Poster: Feiz-Erfan I, Bruner JM, Dacey RG Jr, McCutcheon IE. Conference. North American Skull Base Society. Chicago, IL, US.
138. 2007. Endocrine evaluation and treatment of pituitary tumors. Invited. Practical Clinic on Practical and Technical Aspects of Transsphenoidal Surgery, American Association of Neurological Surgeons, 75th Annual Meeting. Washington, DC, US.
139. 2007. Myxopapillary ependymoma of the fourth ventricle: report of a unique case and review of the literature/Poster: Li J, Aizenberg M, Powell SZ, McCutcheon IE, Fuller GN. Conference. American Association of Neuropathologists. Washington, DC, US.
140. 2007. Awake craniotomy for brain tumors near eloquent cortex: correlation in 300 consecutive patients/Poster: Kim S, McCutcheon IE, Sawaya R, Weinberg JS, Lang FF, Heimberger A, DeMonte F, Hassenbusch SJ, Rhines LD, Ferson DZ, Wefel J, Suki D, Prabhu SS. Conference. American Association of Neurological Surgeons, 75th Annual Meeting. Washington, DC, US.
141. 2006. Surgical overview - What is new?. Invited. Putting It All Together, December in the Desert 2006, Pituitary Network Association's Hormonal Health Symposium. Rancho Mirage, CA, US.
142. 2006. Polypyrimidine tract binding protein and notch 1 are independently re-expressed in glioma. Conference. Society of Neuro-Oncology, 11th Annual Meetiing. Orlando, FL, US.
143. 2006. Polypyrimidine tract binding protein and Notch 1 are independently re-expressed in glioma/Poster: McCutcheon IE, Cheung HC, Corley LJ, Fuller GN, Cote GJ. Conference. Society of Neuro-Oncology. Orlando, FL, US.
144. 2006. Surgical management of primary and metastatic sarcoma of the mobile spine/Poster: Rao G, Feiz-Erfan I, Chakrabarti I, Mody MG, McCutcheon IE, Rhines LD. Conference. Congress of Neurological Surgeons, Annual Meeting. Chicago, IL, US.
145. 2006. Visual outcomes after surgical resection of anterior skull base meningiomas presenting with visual loss/Poster: Guthikonda B, McCutcheon IE, DeMonte F. Conference. Congress of Neurological Surgeons. Chicago, IL, US.
146. 2006. Extent of resection does increase survival in a select group of patients with newly diagnosed untreated anaplastic astrocytoma (WHO III)/Poster: Feiz-Erfan I, Suki D, Cohen Z, Shi W, Heimberger A, Weinberg J, Rhines LD, Fuller GN, McCutcheon IE, et al. Conference. Congress of Neurological Surgeons, Annual Meeting. Chicago, IL, US.
147. 2006. Hypophysitis and autoimmune thyroid disease with ophthalmopathy during treatment with cytotoxic T lymphocyte-associated antigen 4 (CTLA4) blockade/Poster: Shaw S, Sarlis NJ, McCutcheon IE, Kim S, Camacho LH, Waguespack SG. Conference. Endocrine Society, 88th Annual Meeting. Boston, MA, US.
148. 2006. Prevalence of spinal abnormalities in neurofibromatosis type-1/Poster: McCutcheon IE, Thomas A, Slopis JM. Conference. Neurofibromatosis Consortium Conference. Aspen, CO, US.
149. 2006. Does change in intraoperative ACTH levels predict postoperative status of Cushing's disease?/Poster: Guthikonda B, Waguespack SG, McCutcheon IE. Conference. American Association of Neurological Surgeons. San Francisco, CA, US.
150. 2006. Endocrine evaluation and treatment of pituitary tumors, Practical and technical aspects of transsphenoidal surgery. Invited. American Association of Neurological Surgeons, 74th Annual Meeting. San Francisco, CA, US.
151. 2006. Metastatic chordoma within the spine: a 20-year experience/Poster: McPherson C, McCutcheon IE, Rhines LD, Mendel E. Conference. American Association of Neurological Surgeons. San Francisco, CA, US.
152. 2006. Efficacy of transseptal transsphenoidal surgery in correcting visual symptoms caused by hematogenous metastases to the sella and pituitary gland/Poster: Feiz-Erfan I, White WL, McCutcheon IE. Conference. North American Skull Base Society. Phoenix, AZ, US.
153. 2005. Activation of STAT-3 and STAT-1 DNA binding in human meningioma cells by gp 130 cytokines and by insulin-like growth factor-1/Poster: McCutcheon IE, Li JT, Bian K, Zhang AL, Murad F. Conference. Congress of Neurological Surgeons. Boston, MA, US.
154. 2005. Transpedicular vertebrectomy for resection of vertebral metastasis in the era of modern spinal instrumentation/Poster: Dagnew E, McCutcheon IE, Rhines LD, Mendel E. Conference. Congress of Neurological Surgeons. Boston, MA, US.
155. 2005. Nitrotyrosine formation and overexpression of inducible nitric oxide synthase in malignant meningioma/Poster: Bian K, Li JT, Murad F, McCutcheon IE. Conference. American Association of Cancer Research, 96th Annual Meeting. Anaheim, CA, US.
156. 2004. Complication avoidance in transsphenoidal surgery. Invited. Congress of Neurological Surgeons, Annual Meeting. San Francisco, CA, US.
157. 2004. Difficult pituitary problems: options and solutions. Invited. Office of Research on Women’s Health/National Institutes of Health, Symposium on Family Hormonal Health. Bethesda, MD, US.
158. 2004. Surgical naunces of Cushing's disease. Invited. Transsphenoidal Surgery, American Assoication of Neurological Surgeons, Annual Meeting. Orlando, FL, US.
159. 2004. Stereotactic radiosurgery for recurrent glioblastoma multiforme/Poster: Mahajan A, Maor M, McCutcheon IE. Conference. American Radium Society. Napa Valley, CA, US.
160. 2004. Stereotactic radiosurgery for spinal metastases: a neurosurgical perspective. Invited. Course on Radiosurgery: The Art of Science and Dose Planning, American Association of Neurological Surgeons. Orlando, FL, US.
161. 2003. Surgery for pituitary tumors. Invited. Pituitary Conference, December in the Desert, Hormonal Health Symposium, Pituitary Network Association. Rancho Mirage, CA, US.
162. 2003. Advances in pituitary surgery. Invited. Pituitary Network Association. Rancho Mirage, CA, US.
163. 2003. In vitro models of meningioma. Invited. Education Day, Society of Neuro-Oncology, 8th Annual Meeting. Keystone, CO, US.
164. 2003. Stereotactic radiosurgery for spinal and paraspinal metastasis. Invited. Radionics Seminar on Image-Guided Surgery, Congress of Neurological Surgeons, 53rd Annual Meeting. Denver, CO, US.
165. 2002. Surgical resection of anaplastic astrocytoma: prognostic factors and outcome/Poster: Cohen ZR, Suki D, Shi W, Weinberg JS, DeMonte F, McCutcheon IE, Hassenbusch SJ, Gokaslan ZL, Rhines LD, Sawaya R, Lang FF. Conference. Society for Neuro-Oncology. San Diego, CA, US.
166. 2002. Expression of the RNA splicing regulator polypyrimidine tract-brinding protein in normal and neoplastic brain/Poster: McCutcheon IE, Fuller GN, Jin W, Cote GJ. Conference. Society of Neuro-Oncology. San Diego, CA, US.
167. 2002. Surgery for acromegaly. Invited. Endocrine Care Meeting. New Orleans, LA, US.
168. 2002. Surgical treatment of metastatic breast cancer to the spine in 85 patients: results and outcome/Poster: Shehadi JA, McCutcheon IE, Maldaun MV, Suki D, Bonnen M, Symmans F, Rhines LD, Gokaslan ZL. Conference. Congress of Neurological Surgeons. Philadelphia, PA, US.
169. 2002. Acromegaly: Surgical treatment and patient issues. Invited. 2002 Pituitary Patient Congress Conference. Rancho Mirage, CA, US.
170. 2002. Surgical resection of anaplastic astrocytoma: prognostic factors and outcome/Poster: Cohen ZR, Abi-Said D, Shi W, DeMonte F, McCutcheon IE, Hassenbusch SJ, Gokaslan ZL, Weinberg JS, Sawaya R, Lang FF. Conference. American Association of Neurological Surgeons. Chicago, IL, US.
171. 2002. Awake craniotomy for parenchymal brain tumors: patient selection, technique, and outcome/Poster: Prabhu SS, Weinberg JS, Ferson D, Lang FF, McCutcheon IE, Rhines L, Hassenbusch SJ, Gokaslan ZL, DeMonte F, Sawaya R. Conference. 5th Biennial Satellite Symposium, Joint Section on Tumors. Chicago, IL, US.
172. 2002. Chemotherapy and biological therapy for meningiomas. Invited. American Association of Neurological Surgeons, Annual Meeting. Chicago, IL, US.
173. 2002. Posterolateral approaches to the spine. Invited. American Association of Neurological Surgeons, Annual Meeting. Chicago, IL, US.
174. 2002. Induction of apoptosis in primary meningioma cells with fenretinide/Poster: Puduvalli V, Li J, McCutcheon IE. Conference. American Association of Cancer Research. San Francisco, CA, US.
175. 2001. Growth hormone receptor antagonist therapy alone or in combination with topoisomerase inhibitor in a mouse model of colonic carcinoma/Poster: Friend KE, McCutcheon IE, Flyvberg A, Scarlett A. Conference. Endocrine Society. Denver, CO, US.
176. 2001. Modulation of insulin-like growth factors in meningiomas and other tumors/Poster: McCutcheon IE. Conference. Research Society of Neurological Surgeons. Portland, OR, US.
177. 2001. Use of intraoperative ACTH concentrations in the surgical management of Cushing's disease/Poster: Fernandes JK, Friend KE, Maple S, McCutcheon IE. Conference. American Association of Clinical Endocrinology. San Antonio, TX, US.
178. 2000. The GH/IGF-1 system in malignant gliomas: in vitro and in vivo studies/Poster: McCutcheon IE, Friend KE, Khandwala HM, Flyvbjerg A, Hill H, Li J. Conference. 4th Biennial Brain Tumor Satellite Symposium, Joint Section on Tumors. San Francisco, CA, US.
179. 2000. Surgical resection of primary insular tumors: complicaiton avoidance/Poster: Olansen N, DeMonte F, Sawaya R, McCutcheon IE, Gokaslan ZL, Holland E, Abi-Said D, Shi WM, Lang FF. Conference. Congress of Neurological Surgeons. San Antonio, TX, US.
180. 2000. Visualization of CSF leakage is associated with shortened effective tracer half-life (Te) during a whole-body cisternogram/Poster: Wong FC, Kim EE, Jaeckle KA, McCutcheon IE, Podoloff DA. Conference. Society of Nuclear Medicine. St. Louis, MO, US.
181. 2000. The clinical spectrum of neurofibromatosis type 1. Invited. American Association of Neurological Surgeons. San Francisco, CA, US.
182. 2000. Development of an animal model of meningioma: analysis by small-animal MRI/Poster: Van Furth W, Fehlings ME, McCutcheon IE, Rutka J. Conference. North American Skull Base Society. Scottsdale, AZ, US.
183. 1999. Complications with sublabial and endonasal dissections. Invited. Congress of Neurological Surgeons. Boston, MA, US.
184. 1999. Imaging-based necrosis and the survival of patients with glioblastoma multiforme/Poster: Abi-Said D, Lacroix M, Shi WM, Gokaslan ZL, Hess K, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Michael C, Miller D, Sawaya R. Conference. Society for Neuro-Oncology. Scottsdale, AZ, US.
185. 1999. Gliosarcoma: clinical presentation and prognostic indicators in a series of 61 patients/Poster: Sloan A, McCutcheon IE, Barnholtz J, Bruner J, Bondy M. Conference. Society for Neuro-Oncology. Scottsdale, AZ, US.
186. 1999. Brain metastasis from germ cell tumors of testis: factors affecting prognosis and outcome/Poster: Fitzgerald L, McCutcheon IE. Conference. Congress of Neurological Surgeons. Boston, MA, US.
187. 1999. The growth hormone receptor antagonist B2036PEG (Trovert) inhibits the growth of breast cancer xenografts in nude mice/Poster: Roshan SY, McCutcheon IE, Bennett WF, Hill HL, Scarlett JA, Flyvbjerg A, Friend KE. Conference. Endocrine Society. San Francisco, CA, US.
188. 1999. Resection of calvarial metastases overlying dural sinuses/Poster: Michael C, McCutcheon IE, Gokaslan ZL, DeMonte F, Sawaya R, Lang FF. Conference. Congress of Neurological Surgeons. Boston, MA, US.
189. 1999. The growth hormone receptor antagonist B2036PEG (Trovert) inhibits the growth of meningioma xenografts in nude mice/Poster: McCutcheon IE, Bennett WF, Hill HL, Li J, Radinsky R, Zhang BM, Friend KE. Conference. American Association for Cancer Research. Philadelphia, PA, US.
190. 1999. Concurrent craniotomies for multifocal intracranial tumors/Poster: McCutcheon IE, Perez-Cruet MJ, Abi-Said D, Sawaya R. Conference. American Association of Neurological Surgeons. New Orleans, LA, US.
191. 1999. Extent of tumor resection and survival of patients with glioma/Poster: Lacroix M, Abi-Said D, Shi WM, DeMonte F, Gokaslan ZL, Lang FF, McCutcheon IE, Hassenbusch SJ, Sawaya R. Conference. American Association of Neurological Surgeons. New Orleans, LA, US.
192. 1999. Gliosarcoma: clinical presentation and prognostic indicators in a series of 61 patients/Poster: Sloan A, McCutcheon IE, Barnholtz J, Bruner J, Bondy M. Conference. American Association of Neurological Surgeons. New Orleans, LA, US.
193. 1999. Concurrent craniotomies for multifocal intracranial tumors/Poster: Perez-Cruet MJ, Sawaya R, McCutcheon IE. Conference. Air Force Clinical Surgeons Meeting. San Antonio, TX, US.
194. 1999. An aggressive multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion can lead to long-term survival/Poster: Gandhi S, Walsh GL, Komaki R, Gokaslan ZL, Nesbitt JC, Putnam JB Jr, Roth JA, Merriam KW, McCutcheon IE, et al. Conference. Society of Thoracic Surgeons. San Antonio, TX, US.
195. 1998. Growth hormone receptor expression and function in meningiomas: effects of a GH receptor antagonist/Poster: McCutcheon IE, Zhang BM, Ang L, Friend KE. Conference. Society for Neuro-Oncology. San Francisco, CA, US.
196. 1998. Commissural myelotomy in the management of intractable cancer pain/Poster: Narka K, McCutcheon IE, Payne R. Conference. Society of Neuro-Oncology. San Francisco, CA, US.
197. 1998. Somatosensory evoked potentials for cortical mapping in patients with paracentral tumors/Poster: McCutcheon IE, Kanaan SV, Sankhla S, Moore BA III, DeMonte F, Sawaya R. Conference. Society of Neuro-Oncology. San Francisco, CA, US.
198. 1998. Melanoma metastatic to brain: prognostic factors and results of treatment/Poster: McCutcheon IE, Nardone E, Luiz J, Hess K, Plager C. Conference. Congress of Neurological Surgeons, Annual Meeting. Seattle, WA, US.
199. 1998. Somatosensory evoked potentials for cortical mapping in patients with paracentral tumors/Poster: McCutcheon IE, Kanaan SV, Sankhla S, Moore BA III, DeMonte F, Sawaya R. Conference. Congress of Neurological Surgeons, Annual Meeting. Seattle, WA, US.
200. 1998. Growth hormone receptor expression and function in meningiomas: effects of a GH receptor antagonist/Poster: McCutcheon IE, Zhang BM, Ang L, Fiend KE. Conference. 3rd Biennial Brain Tumor Satellite Symposium, Joint Section on Tumors. Philadelphia, PA, US.
201. 1998. Management strategies for Cushing’s disease. Invited. American Association of Neurological Surgeons. Denver, CO, US.
202. 1998. Hemangioblastomas and von Hippel-Lindau disease. Invited. American Association of Neurological Surgeons. Denver, CO, US.
203. 1998. Elevated expression of p21 (WAF/Cip1) in hormonally active pituitary adenomas/Poster: Fuller GN, Babaian A, Ruan S, Ruiz M, Rhee CH, McCutcheon IE, Zhang W. Conference. American Society of Clinical Pathology. Los Angels, CA, US.
204. 1998. Growth hormone receptor expression and function in meningiomas/Poster: McCutcheon IE, Zhang BM, Ang L, Friend KE. Conference. American Association of Neurological Surgeons, Annual Meeting. Philadelphia, PA, US.
205. 1998. GH/IGF-1 axis in meningiomas: GH receptor expression/effects of IGF-1 on primary culture growth rates/Poster: McCutcheon IE, Zhang BM, Ang L, Friend KE. Conference. Endocrine Society. New Orleans, LA, US.
206. 1997. Carcinomas of the prostate metastatic to brain: prognostic factors and results of treatment/Poster: Eng DY, McCutcheon IE. Conference. American Association of Neurological Surgeons, Annual Meeting. Denver, CO, US.
207. 1997. Alterations in adenosine metabolites adjacent to an infiltrating glioma: a microdialysis study in free-roaming rats/Poster: Akeyson EW, McCutcheon IE. Conference. American Association of Neurological Surgeons, Annual Meeting. Denver, CO, US.
208. 1997. Transthoracic vertebrectomy in cancer patients/Poster: Gokaslan ZL, McCutcheon IE, Walsh GL, Putnam JB Jr, Nesbitt JC. Conference. American Association of Neurological Surgeons. Denver, CO, US.
209. 1997. Endocrine workup for pituitary adenomas. Invited. American Association of Neurological Surgeons. Denver, CO, US.
210. 1997. Cervical thoracic stabilization and fusion in cancer patients/Poster: Gokaslan ZL, McCutcheon IE, Lang FF, Sawaya R. Conference. Joint Section on Disorders of the Spine and Peripheral Nerves, 13th Annual Meeting. Newport Beach, CA, US.
211. 1997. Anterior approaches to the thoracic spine in patients with cancer: indications and results/Poster: Walsh GL, Gokaslan ZL, McCutcheon IE, Mineo MT, Yasko A, Swisher SG, Schrump DS, Nesbitt JC, Putnam JB Jr, Roth JA. Conference. Society of Thoracic Surgeons. San Diego, CA, US.
212. 1997. Textiloma (hemostat-associated intracranial mass lesions): clinicopathologic evaluation of a series in brain tumor patients/Poster: Fuller GN, Kumar AJ, McCutcheon IE, Langford LA, Bruner JM, DeMonte F, Hassenbusch SJ, Moser RP, Leeds NE. Conference. Society for Neuro-Oncology. Charlottesville, VA, US.
213. 1997. Transthoracic vertebrectomy in cancer patients/Poster: Gokaslan ZL, McCutcheon IE, Walsh GL, Putnam JB, Nesbitt JC. Conference. North American Spine Society. New York, NY, US.
214. 1997. Pharmacokinetic mapping of intracranial neoplasms using dynamic contrast: acquisition, processing, display, and analysis/Poster: Reeve DM, Jackson EF, McCutcheon IE, Hazle JD. Conference. American Association of Physcis in Medicine. Milwaukee, WI, US.
215. 1997. Favorable response of progressive multifocal leukoencephalopathy (PML) to treatment with interleukin-2/Poster: Jaeckle KA, Przepiorka D, Birdwell RR, McCutcheon IE, Fuller GN. Conference. American Academy of Neurology. Boston, MA, US.
216. 1996. Expression of cysteine protease inhibitors in gliomas and meningiomas/Poster: Sivaparvathi M, McCutcheon IE, Sawaya R, Rao JS. Conference. Society for Neuro-Oncology. Santa Fe, NM, US.
217. 1996. Intracranial injection of meningioma cell lines in athymic mice: an orthotopic animal model for meningioma growth/Poster: McCutcheon IE, Gerdes TM, Zhang BM, Fuller GF. Conference. Society of Neuro-Oncology. Santa Fe, NM, US.
218. 1996. Dynamic contrast-enhanced MRI for guidance of intracranial stereotactic biopsy/Poster: McCutcheon IE, Jackson EF, Schomer DF, Hassenbusch SJ, Reeve DM, Leeds NE, Hazle JD. Conference. Society for Neuro-Oncology. Santa Fe, NM, US.
219. 1996. Colorectal carcinoma and brain metastasis/Poster: McCutcheon IE, Hammoud MA, Schoppe D, Elsouki R, Patt YZ. Conference. American Association of Neurological Surgeons, Annual Meeting. Minneapolis, MN, US.
220. 1996. Colorectal carcinoma and brain metastasis/Poster: McCutcheon IE, Hammoud MA, El-Souki R, Schoppe D, Patt YZ. Conference. Society of Surgical Oncology. Atlanta, GA, US.
221. 1996. The use of dynamic contrast-enhanced MRI for guidance of stereotactic brain biopsy/Poster: Jackson EF, Schomer DF, McCutcheon IE, Reeve DM, Leeds NE, Hazle JD. Conference. Radiological Society of North America. Chicago, IL, US.
222. 1995. Use of laser-induced tissue autofluorescence to confirm the localization of deep intracerebral masses/Poster: Chow TSF, McCutcheon IE, Schwartz J, Jacquest SL. Conference. Congress of Neurological Surgeons, Annual Meeting. San Francisco, CA, US.
223. 1995. Anterior thoracic/lumbar reconstruction and instrumentation using synthes thoracolumbar locking plate/screws in cancer patients/Poster: Gokaslan Z, McCutcheon IE, Walsh GL, Sawaya R. Conference. Congress of Neurological Surgeons, Annual Meeting. San Francisco, CA, US.
224. 1995. Magnetic resonance image quality in the presence of titanium spinal implants/Poster: Gokaslan Z, McCutcheon IE, Schomer DF, Sawaya R. Conference. Congress of Neurological Surgeons, Annual Meeting. San Francisco, CA, US.
225. 1995. Diagnostic potential of laser-induced autofluorescence emission in brain tissue/Poster: Chong YG, Schwartz JA, Gardner CM, McCutcheon IE, Sawaya R, Jacques SL. Conference. American Association of Neurological Surgeons, Annual Meeting. Orlando, FL, US.
226. 1995. The surgical management of intradural extramedullary metastatic tumors of the spine/Poster: Chow T, McCutcheon IE. Conference. American Assoication of Neurological Surgeons, Annual Meeting. Orlando, FL, US.
227. 1995. Results of single-stage, posterior vertebral body resection/replacement combined with posterior instrumentation for symptomatic spinal metastases/Poster: Akeyson EW, McCutcheon IE. Conference. American Association of Neurological Surgeons, Annual Meeting. Orlando, FL, US.
228. 1995. Craniofacial resection for aggressive non-melanoma skin cancer (NMSC) of the head and neck/Poster: Backous DD, Weber RS, DeMonte F, McCutcheon IE. Conference. North American Skull Base Society. Naples, FL, US.
229. 1995. Anterior approach for an advanced superior sulcus tumor (video movie)/Poster: Nesbitt JC, Morris PT, McCutcheon IE. Conference. Society of Thoracic Surgeons. Palm Springs, CA, US.
230. 1994. Hemangioblastomas of the spinal cord. Invited. Congress of Neurological Surgeons, 44th Annual Meeting. Chicago, IL, US.
231. 1994. Inverse expression of neurotrophin receptor and nerve growth factor at the invasion front of brain-metastatic human melanoma tissues/Poster: Marchetti D, Ross MI, McCutcheon IE, Nicolson GL. Conference. American Association of Cancer Research. San Francisco, CA, US.
232. 1994. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody/Poster: Mohanam S, Sawaya R, McCutcheon IE, Boyd D, Henkin J, Rao JS. Conference. American Association of Neurological Surgeons, Annual Meeting. San Francisco, CA, US.
233. 1993. Transcranial resection of tumors of the paranasal sinuses/Poster: McCutcheon IE, Blacklock JB, Weber R, Moser RP, Byers M. Conference. American Association of Neurological Surgeons, Annual Meeting. Boston, MA, US.
234. 1993. Transcranial resection of tumors of the paranasal sinuses/Poster: McCutcheon IE, Blacklock JB, Weber RS, DeMonte F, Moser RP, Byers M, Goepfert H. Conference. North American Skull Base Society. Scottsdale, AZ, US.
235. 1993. Suppression of FDG uptake in brain tumor during hyperglycemia/Poster: Wong FCL, Kim EE, Wong WH, McCutcheon IE, Kyritisis A, Haynie TP. Conference. Radiological Society of North America. Chicago, IL, US.
236. 1993. Neurotrophins effects on human melanoma cell invasion/Poster: Marchetti D, Menter D, Kapoor Pencil S, Herrmann J, Nakajima M, McCutcheon IE, Nicolson GL. Conference. Symposium on Fundamental Cancer Research, 46th Annual Meeting. Houston, TX, US.
237. 1993. Neurotrophins effects on human melanoma cell invasion/Poster: Marchetti D, Menter D, Kapoor R, Pencil S, Hermann J, Nakajima M, McCutcheon IE, Nicolson GL. Conference. Fundamental Cancer Research, 46th Annual Symposium. Houston, TX, US.
238. 1992. History of stereotactic surgery. Invited. Congress of Neurological Surgeons, 42nd Annual Meeting. Washington, DC, US.
239. 1992. Sensorimotor cortex localization using somatosensory evoked potentials in tumor surgery/Poster: Jackson R, McCutcheon IE, Sawaya R, Forman A. Conference. American Electroencephalographic Society. San Francisco, CA, US.
240. 1991. The microvascular anatomy of dural arteriovenous malformations of the spine/Poster: McCutcheon IE, Doppman J, Oldfield EH. Conference. American Association of Neurological Surgeons, Annual Meeting. New Orleans, LA, US.
241. 1990. Major histocompatibility antigen and lymphocytes in pituitary tumors/Poster: McCutcheon IE, Laws ER Jr, Oldfield EH. Conference. American Association of Neurological Surgeons, Annual Meeting. Nashville, TN, US.
242. 1990. Early and late local cellular response to cortical trauma in monkeys/Poster: McCutcheon IE, Plunkett R, Bankiewicz K, Gress R, Oldfield EH. Conference. American Association of Neurological Surgeons, Annual Meeting. Nashville, TN, US.
243. 1989. Adoptive immunotherapy of intracerebral metastases in mice/Poster: McCutcheon IE, Baranco RA, Katz DA, Saris SC. Conference. American Association of Neurological Surgeons, Annual Meeting. Washington, DC, US.
244. 1989. The local cellular immune response to intracerebral dopaminergic allografts in rhesus monkeys/Poster: McCutcheon IE, Plunkett R, Gress R, Bankiewicz K, Oldfield EH. Conference. American Association of Neurological Surgeons, Annual Meeting. Washington, DC, US.
245. 1989. Continuous sampling of cerebrospinal fluid (CSF) in patients with major depression and controls: a new technique for studying neurohormone secretion in the central nervous system (CNS)/Poster: Kling MA, Geracioti TD, McCutcheon IE, Listwak SJ, et al. Conference. American Association for Clinical Neuropsychopharmacology. Maui, HI, US.

International Presentations

1. 2025. Scientific Session 7: Cerebrovascular & Tumor Basic Science Plus Dr. Irresistible, Moderators: Rose Du & Ian McCutcheon. Athens, GR.
2. 2025. Distinguishing Prolactinomas from Nonfunctional Pituitary Adenomas in Patients with Hyperprolactinemia: Multivariate Analysis and Creation of a Predictive Nomogram. Invited. Niagara Falls, CA.
3. 2025. Mechanisms of extra-central nervous system metastasis from GBM. Invited. San Juan, PR.
4. 2025. The utility of routine postoperative CT to screen for hemorrhage after stereotactic biopsy (SBB) remains controversial, as post-biopsy hemorrhage rates vary widely (1-60%). Invited. San Juan, PR.
5. 2024. SRS for treatment of pituitary tumors. Invited. 1st Stereotactic Radiosurgery Webinar, US.
6. 2024. Von Hippel-Lindau disease and the neurosurgeon: the challenge of the hemangioblastoma. Visiting. Virtual Grand Rounds, US.
7. 2023. Speaker, Preoperative (neoadjuvant) SRS before Resection of Large Brain Metastases, SRS/SRT in Management of Intracranial Metastases, Parenchymal Brain Tumors, Genitourinary, Gynecological, and Abdominal Cancers; Medical Physics and Imaging for Radiosurgery. Invited. ISRS (International Stereotactic Radiosurgery Society). Istanbul, TR.
8. 2023. Speaker, Overview of Metastasis to Brain from Solid Tumors, SRS/SRT in Management of Intracranial Metastases, Parenchymal Brain Tumors, Genitourinary, Gynecological, and Abdominal Cancers; Medical Physics and Imaging for Radiosurgery. Invited. ISRS (International Stereotactic Radiosurgery Society). Istanbul, TR.
9. 2022. Role of SRS/SRT in Management of Hormone-secreting Pituitary Adenomas, ISRS Educational Course “SRS/SRT in Management of Benign Intracranial Tumors, Skull Base Tumors, Prostate and Renal Cancers; Medical Physics for Radiosurgery”. Invited. Role of SRS/SRT in Management of Hormone-secreting Pituitary Adenomas, ISRS Educational Course “SRS/SRT in Management of Benign Intracranial Tumors, Skull Base Tumors, Prostate and Renal Cancers; Medical Physics for Radiosurgery”, CR.
10. 2022. Radiosurgery of Glomus Tumors, ISRS Educational Course “SRS/SRT in Management of Benign Intracranial Tumors, Skull Base Tumors, Prostate and Renal Cancers; Medical Physics for Radiosurgery”. Invited. Radiosurgery of Glomus Tumors, ISRS Educational Course “SRS/SRT in Management of Benign Intracranial Tumors, Skull Base Tumors, Prostate and Renal Cancers; Medical Physics for Radiosurgery”, CR.
11. 2021. John I, Foster AP, Haymaker CL, Bassett RL, Lee JJ, Rohlfs ML, Richard J, Iqbal M, McCutcheon IE, Ferguson SD, Heimberger AB, Saberian CM, O’Brien BJ, Tummala S, Guha-Thakurta N, Debnam M, Burton EM, Tawbi HA, Burton EM, Davies MA, Glitza IC: Intrathecal and intravenous anti-PD1 therapy for melanoma patients with LMD. Conference. Virtual meeting, American Society of Clinical Oncology, Annual Meeting, US.
12. 2020. Efficacy of salvage Gamma Knife radiosurgery in recurrent high-grade gliomas. Conference. [Virtual] Global Academic Programs Conference, Peter MacCallum Cancer Centre. Melbourne, AU.
13. 2020. Neuropsychological and Neuropsychiatric Mimics in Neurosurgical Oncology. Invited. ISIS 2020, Neurosurgical Mgmt of Psychiatric Disorders. Novosibirsk, RU.
14. 2020. Seizures and Pseudo-seizures: The Great Divide. Invited. ISIS 2020, Neurosurgical Mgmt of Psychiatric Disorders. Novosibirsk, RU.
15. 2019. Malignant degeneration in neurofibromatosis type 1: studies in the biology of malignant peripheral nerve sheath tumors. Invited. Bezmiàlem Vakif University, Department of Neurosurgery. Istanbul, TR.
16. 2019. The role of stereotactic radiosurgery and radiotherapy in managing pituitary adenomas. Invited. Educational Course of the International Stereotactic Radiosurgery Society. Tbilisi, GE.
17. 2019. Stereotactic radiosurgery for skull base malignancies. Invited. Educational Course of the International Stereotactic Radiosurgery Society. Tbilisi, GE.
18. 2019. Preoperative stereotactic radiosurgery before resection of large brain metastases. Invited. Educational Course of the International Stereotactic Radiosurgery Society. Tbilisi, GE.
19. 2019. The problem of the invasive pituitary adenoma: surgical nuances and techniques. Invited. Bezmiàlem Vakif University, Department of Neurosurgery. Istanbul, TR.
20. 2019. Glitza IC, Bishop AJ, Ma JS, Li J, McCutcheon IE, Tatsui CE, Guadagnolo BA: Outcomes of patients with primary central nervous system melanoma. Conference. Glitza IC, Bishop AJ, Ma JS, Li J, McCutcheon IE, Tatsui CE, Guadagnolo BA: Outcomes of patients with primary central nervous system melanoma. Rio de Janeiro, BR.
21. 2019. Stereotactic radiosurgery for critically located brain metastases. Invited. Educational Course of the International Stereotactic Radiosurgery Society. Debrecen, HU.
22. 2019. Radiosurgery of Skull Base Malignancies, Session IV, SRS/SRT for Head and Neck Cancer,. Invited. ISRS 2019 Educational Course. Cairo, EG.
23. 2019. Role of SRS/SRT in Management of Pituitary Adenomas, Session III, SRS/SRT of Sellar Tumors, ISRS 2019 Educational Course. Invited. Role of SRS/SRT in Management of Pituitary Adenomas, Session III, SRS/SRT of Sellar Tumors, ISRS 2019 Educational Course. Cairo, EG.
24. 2018. Kochat V, Raman A, Landers SM, Terranova C, Wu CC, Mao X, Ingram D, Mulder ZA, Yeagley MA, Bierd H, Bhalla A, McCutcheon IE, Slopis J, Zhang J, Futreal A, Wang WL, Lazar A, Rai K, Torres KE: Poster: Chromatin state transitions associated with PRC2 functional loss drive a dedifferentiated phenotype in malignant peripheral nerve sheath tumors. Conference. Connective Tissue Oncology Society. Rome, IT.
25. 2018. Radiosurgery for skull base malignancies. Invited. Educational Course of the International Stereotactic Radiosurgery Society. Tianjin, CN.
26. 2018. Contemporary management of malignant intracranial gliomas. Invited. Annual Meeting of Tianjin Associations of Neurosurgeons. Tianjin, CN.
27. 2018. Advanced neurosurgical technologies used at the M. D. Anderson Cancer Center. Invited. Tokyo Women’s Medical University, Faculty of Advanced Techno-Surgery. Tokyo, JP.
28. 2018. Pituitary tumors: an overview. Invited. 8th Meeting of the Asian Gamma Knife Academy/9th Educational Course of the Asian Congress of Neurological Surgeons. Khabarovsk, RU.
29. 2018. Radiosurgery of skull base malignancies. Invited. 8th Meeting of the Asian Gamma Knife Academy/9th Educational Course of the Asian Congress of Neurological Surgeons. Khabarovsk, RU.
30. 2017. Role of surgery in the management of recurrent gliomas. Russian Association of Neurosurgeons, Neurosurgical Conference and Workshop. Invited. Role of surgery in the management of recurrent gliomas. Russian Association of Neurosurgeons, Neurosurgical Conference and Workshop. St. Petersburg, RU.
31. 2017. Advances in management of pituitary tumors, 4th SAARC Federation of Oncologists-Nepal International Cancer Conference. Conference. Advances in management of pituitary tumors, 4th SAARC Federation of Oncologists-Nepal International Cancer Conference. Bharatpur, NP.
32. 2017. Pituitary and parasellar lesions. Invited. 16th World Congress of Neurosurgery, World Federation of Neurosurgical Societies. Istanbul, TR.
33. 2017. Relief of intractable nausea after resection of hemangioblastoma of the distal medulla in patients with von Hippel-Lindau disease: a clinical series. The Society of University Neurosurgeons 2017 Annual Meeting. Invited. Relief of intractable nausea after resection of hemangioblastoma of the distal medulla in patients with von Hippel-Lindau disease: a clinical series. The Society of University Neurosurgeons 2017 Annual Meeting. Cape Town/Johannesburg, ZA.
34. 2017. Santos Pinheira F, McCutcheon IE, Mahajan A, Waguespack SG, Kamiya Matsuoka C, Brown P, Peñas-Prado M/Poster: Pituitary carcinoma: the UT M D Anderson Cancer Center experience. Conference. American Society of Clinical Oncology. Chicago, US.
35. 2017. Jonasch E, Gombos D, Waguespack S, Marcott V, Liu D, Weldon J, Bird S, Robichaux C, Tannir N, Woodson A, Periz JR, Fuller G, McCutcheon IE, Matin S/Poster: Phase II study of pazopanib in patients with von Hippel-Lindau disease. Conference. American Society of Clinical Oncology. Chicago, US.
36. 2017. The role of radiosurgery in managing aggressive pituitary adenomas and carcinomas. Invited. International Stereotactic Radiosurgery Society Educational Course. Kazan, RU.
37. 2017. Radiosurgery to the tumor resection cavity after removal of brain metastases: results of a prospective randomized trial. Invited. International Stereotactic Radiosurgery Society Educational Course, Plenary lecture. Kazan, RU.
38. 2017. The role of radiosurgery in treating benign pituitary adenomas. Invited. International Stereotactic Radiosurgery Society Educational Course. Kazan, RU.
39. 2016. The surgical challenge of the atypical adenoma. Conference. 14th Meeting of the International Pituitary Pathology Club. Annécy, FR.
40. 2016. Developing rational medical therapies for von Hippel-Lindau disease: the dilemma of hemangioblastomas in the brain and spinal cord. Invited. 21st International Charles Heidelberger Symposium on Cancer Research. Moscow, RU.
41. 2016. Malignant gliomas: the evidence for maximizing resection. Invited. International Scientific School for Young Scientists, Symposium on Fundamental and Clinical Oncology, Moscow Institute of Physics and Technology. Moscow, RU.
42. 2015. The surgical treatment of tumors of the fourth ventricle. Invited. The Society of University of Neurosurgeons 2015 Annual Meeting Jointly Provided by the American Association of Neurological Surgeons. Shanghai, CN.
43. 2014. Identification of molecular drivers of human hemangioblastoma: novel function of HNF1β. Sun M, Monzon F, Zhou L, Liu X, Ding Z, Zhang X, Bai S, German P, Kalra S, Zhang J, Futreal A, Powell R, Park I-Y, Dere R, Tong X, Berry T, Walker C, Tannir N, Matin S, Fuller G, McCutcheon IE, Jonasch E. Invited. 11th International VHL Symposium. Madrid, ES.
44. 2014. Controversy and new directions in managing high-grade gliomas. Invited. Third International Congress of Neuro-Oncology. São Paulo, BR.
45. 2014. Surgery for low-grade gliomas: maximizing safe resection in eloquent areas. Invited. Third International Congress of Neuro-Oncology. São Paulo, BR.
46. 2014. Management of cerebral metastases: state of the art. Invited. Third International Congress of Neuro-Oncology. São Paulo, BR.
47. 2014. Role of Gamma Knife radiosurgery in management of pituitary adenomas. Invited. Sixth Asian Gamma Knife Academy. Shanghai, CN.
48. 2014. Gamma Knife radiosurgery for malignant tumors at the skull base. Invited. Keynote Address. Shanghai, CN.
49. 2013. Multivariate analysis of prolactinoma vs. nonfunctional pituitary adenoma by clinical and imaging characteristics/Poster: Prasad GP, Waguespack S, McCutcheon IE. Conference. European Association of Neurosurgical Societies/Joint Tumor Section of the AANS/CNS. Tel Aviv, IL.
50. 2013. IDH1 status as a complementary marker for diagnosing malignant astrocytomas from surgical specimens of different sizes/Poster: McCutcheon IE, Kim BYS, Jiang W, Prabhu SS, Sawaya R, Aldape K, Cahill DP. Conference. European Association of Neurosurgical Societies/Joint Tumor Section of the AANS/CNS. Tel Aviv, IL.
51. 2013. Extracapsular resection of prolactinomas: lessons learned from a series of 50 cases. Conference. 13th Annual Meeting of the International Pituitary Pathology Club. Medellin, CO.
52. 2013. Roundtable discussion: Classification and criteria of malignancy in pituitary tumors. Conference. 13th Annual Meeting of the International Pituitary Pathology Club. Medellin, CO.
53. 2013. Biological targets in pituitary tumors. Conference. 13th Annual Meeting of the International Pituitary Pathology Club. Medellin, CO.
54. 2013. Pituitary adenomas: lessons from the age of molecular diagnostics and pathology. Conference. 13th Annual Meeting of the International Pituitary Pathology Club. Medellin, CO.
55. 2013. Interactive Session on Neuro-Oncology, Invasive giant pituitary adenoma: techniques and complications. Conference. XV Meeting of the World Federation of Neurosurgical Societies. Seoul.
56. 2013. IDH1 status as a complementary marker for malignant astrocytomas with limited surgical specimen volume/Kim BYS, Jiang W, Beiko J, Prabhu SS, Sawaya R, Suki D, Aldape K, Cahill DP, McCutcheon IE. Conference. XV Meeting of the World Federation of Neurosurgical Societies. Seoul.
57. 2013. Subcortical injury is an independent predictor of worsening neurological deficits following awake craniotomy procedures/Prabhu SS, Trinh VT, Fahim DK, Shah K, Tummala S, McCutcheon IE, Suki D, Sawaya R. Conference. XV Meeting of the World Federation of Neurosurgical Societies. Seoul.
58. 2013. Khiewvan B, Lev DC, McCutcheon IE, Slopis JM, Al Sannaa GA, Macapinlac HA, Chuang HH/Platform Presentation: The value and therapeutic impact of 18F-FDG PET/CT in malignant peripheral nerve sheath tumors. Platform Presentation: Society of Nuclear Medicine and Molecular Imaging. Conference. Society of Nuclear Medicine and Molecular Imaging. Vancouver, CA.
59. 2013. IDH1 status as a complementary marker for malignant astrocytomas with limited surgical specimen. Conference. Society of University Neurosurgeons. Malaga, ES.
60. 2013. Management of Skull Base Malignancies/Modern Opportunities of Neurosurgical Technologies in Neuro-Oncology. Conference. 3rd WFNS Training Course. Odessa, UA.
61. 2013. Modern Surgical Management of Malignant Gliomas/Modern Opportunities of Neurosurgical Technologies in Neuro-Oncology. Conference. 3rd WFNS Training Course. Odessa, UA.
62. 2013. Moderator for Session V: Management of Malignant Skull Base Tumors/Modern Opportunities of Neurosurgical Technologies in Neuro-Oncology. Invited. 3rd WFNS Training Course. Odessa, UA.
63. 2012. Improving surgical outcome by en bloc resection of small pituitary tumors/14th Annual Conference. Invited. Skull Base Surgery Society of India. Mumbai, IN.
64. 2012. Current role of radiosurgery in managing malignant skull base tumors/14th Annual Conference. Invited. Skull Base Surgery Society of India. Mumbai, IN.
65. 2012. Controversies in Skull Base/Session XI, 14th Annual Conference. Invited. Skull Base Surgery Society of India. Mumbai, IN.
66. 2012. IDH1 status and survival benefit from surgical resection of enhancing and non-enhancing tumor in malignant astrocytomas/Poster: Cahill DP, Beiko J, Suki D, Prabhu SS, Weinberg J, Lang FF, Gilbert MR, Rao G, McCutcheon IE, Aldape KD, Sawaya R. Conference. American Society of Clinical Oncology. Chicago, US.
67. 2012. Surgery for gliomas in eloquent cortical areas/IV Course of Neuroncology: “New Horizons in Gliomas Treatment”. Invited. Clínica Alemana. Santiago, CL.
68. 2012. Surgical techniques for removing intrinsic tumors of brain: microsurgery and image-guided surgery/IV Course of Neuroncology: “New Horizons in Gliomas Treatment”. Invited. Clinica Alemana. Santiago, CL.
69. 2011. Current role of radiosurgery in management of malignant extracerebral intracranial tumors. Invited. Fifth Asian Gamma Knife Academy. St. Petersburg, RU.
70. 2011. Treatment of patients with advanced neurofibromatosis type 2 (NF2) with novel molecularly targeted therapies/Poster: Subbiah V, Slopis JM, Hong DS, Angelo LS, McCutcheon IE, Kurzrock R. Invited. American Society of Clinical Oncology. Chicago, US.
71. 2011. Scalp tumors with cranial extension in 60 patients: multidisciplinary surgical strategies and outcomes. Invited. Society of University Neurosurgeons. Istanbul, TR.
72. 2011. Conservative surgery and adjuvant therapy for craniopharyngioma. Invited. Indian Society of Neuro-Oncology. Kolkata, IN.
73. 2011. Management of Cushing’s disease and functional adenomas. Invited. Indian Society of Neuro-Oncology. Kolkata, IN.
74. 2010. The lessons of granulomatous hypophysitis. Conference. International Society of Pituitary Surgeons. Sonoma, US.
75. 2010. Relief of intractable nausea after resection of brainstem hemangioblastoma: a clinical series. Invited. 9th International Medical Symposium on VHL. Rio de Janeiro, BR.
76. 2010. En bloc transsphenoidal resection of prolactin-secreting pituitary tumors/Platfrom Presentation: Siu TL, Fuller GN, Waguespack S, Ying A, McCutcheon IE. Conference. Neurosurgical Society of Australasia. Coolsum, AU.
77. 2010. Treatment of VHL patients with sunitinib: clinical outcomes and translational studies/Poster: Matin SF, McCutcheon IE, Gombos DS, Waguespack S, Tannir NM, Wen S, Davis DW, Smith LA, Fuller G, Jonasch E. Conference. American Society of Clinical Oncology. Chicago, US.
78. 2008. Meningioma incidence in males with carcinoma of the breast: lessons for pathogenesis/McCutcheon IE, Rao G, Lui J, Giordano SH. Invited. 6th International Congress on Meningiomas and Venous System. Boston, US.
79. 2008. Comparative assessment of hemangioblastoma and renal cell carcinoma tissue using laser scanning cytometry/Poster: Jonasch E, McCutcheon IE, Matin S, Lui P, Fuller GN. Conference. 8th International Medical Symposium on von Hippel-Lindau disease. Roskilde, DK.
80. 2007. Evolving strategies for difficult meningiomas: lessons from tumor biology. Conference. 2nd International Meeting for Updates in Neuro-Oncology. Cortona, IT.
81. 2006. Metastasis to the pituitary: Is surgery ever appropriate. Invited. 2006 Meeting of the International Society of Pituitary Surgeons (ISPS). San Carlos de Bariloche, AR.
82. 2006. Managing the difficult meningiomas: strategies for tumor control and cure. Invited. Dutch Society of Neurosurgery, Annual Meeting. Garderen, NL.
83. 2005. Cortical abnormalities in children with neurofibromatosis type 1/Poster: Slopis JM, McCutcheon IE, Ochiai R, Iyengar U, Moore BA. Conference. Children's Tumor Foundation International Consortium for the Molecular and Cell Biology of NF1, NF2, and Schwannomatosis. San Diego, US.
84. 2005. Elevated expression of polypyrimidine tract binding protein does not correlate with suppression of Notch 1 activity in glioblastomas/Poster: Cheung HC, Corley LJ, McCutcheon IE, Fuller GN, Cote GJ. Conference. RNA Society, 10th Annual Meeting. Banff, CA.
85. 2005. Overexpression of inducible nitric oxide synthase and maintenance of the malignant phenotype in meningiomas/Poster: McCutcheon IE, Bian K, Li JT, Murad F. Conference. 2nd Quadrennial Meeting of the World Federation on Neuro-Oncology & 6th Meeting of the European Association of Neuro-Oncology. Edinburgh, GB.
86. 2004. Retinoids and other natural products as therapeutic agents against intracranial tumors. Invited. 2nd International Symposium on Education in Traditional Chinese Medicine. Shanghai, CN.
87. 2004. Cushing's disease: intraoperative hormone measurement/Poster: McCutcheon IE. Conference. International Society of Pituitary Surgeons. Capri, IT.
88. 2002. The clearance rates of In-111 DTPA from CSF vary with different sites of CSF blockade/Poster: Wong FC, Kim E, Groves M, Conrad C, McCutcheon IE, Podoloff D. Conference. European Association of Nuclear Medicine. Vienna, AT.
89. 2001. Treatment of vascular tumors of the spinal cord. Invited. Simpósio Internacional de Cirurgia Neurovascular/International Symposium on Neurovascular Disorders. Rio de Janeiro, BR.
90. 2001. Vascular brain tumors. Invited. Simpósio Internacional de Cirurgia Neurovascular/International Symposium on Neurovascular Disorders. Rio de Janeiro, BR.
91. 2001. FGFR alpha exon exclusion is regulated by polypyrimidine tract-binding protein (PTB)/Poster: Jin W, McCutcheon IE, Fuller GN, Sanger LJ, Cote GJ. Conference. RNA Meeting. Banff, CA.
92. 2001. Tumor grade, neurologic function, and age correlate with outcome in patients with non-ependymoma spinal cord gliomas/Poster: Lee HK, Chang EL, Atkinson GJ, Fuller GN, Levy LB, McCutcheon IE, Maor MH. Conference. European Society for Therapeutic Radiation Oncology. Lisbon, PT.
93. 2001. Frameless stereotactic navigation in transsphenoidal surgery: comparison of the viewscope with fluoroscopy/Poster: McCutcheon IE, Kitagawa RH, DeMasi PF, Law B, Friend KE. Conference. American Association of Neurological Surgeons. Toronto, CA.
94. 2001. Surgical management of Cushing’s disease. Invited. International Congress of Endocrinology, 4th Annual Meeting. Alexandria, EG.
95. 2001. Indications and pitfalls in pituitary surgery. Invited. International Congress of Endocrinology, 4th Annual Meeting. Alexandria, EG.
96. 2000. CSF leakage is associated with shortened effective tracer half-life (Te) during a whole body cisternogram/Poster: Wong FC, Kim EF, Jaeckle KA, McCutcheon IE, Podoloff DA. Conference. European Association of Nuclear Medicine. Paris, FR.
97. 2000. Growth hormone receptor antagonists in the treatment of benign and malignant tumors/Poster: Friend KE, Flyvbjerg A, McCutcheon IE. Conference. 11th NCI-EORTC-AACR Symposium on New Drugs in Cancer Therapy. Amsterdam, NL.
98. 2000. Fibroblast growth factor receptor-1 (FGFR-1) RNA splicing and polypyrimidine tract-binding protein (PTB)/Poster: Jin W, McCutcheon IE, Fuller GN, Huang ESC, Cote GJ. Conference. 11th International Congress of Endocrinology. Sydney, AU.
99. 2000. Development of an orthotopic xenograft meningioma model/Poster: Van Furth WR, Cusimano MD, McCutcheon IE, Laughlin S, Rutka JT. Conference. Canadian Congress of Neuorlogical Sciences. Ottawa, CA.
100. 2000. Growth hormone and insulin-like growth factor-1: effects on growth of glioma cell lines/Poster: Khandwala HM, McCutcheon IE, Flyvbjerg A, Hill H, Friend KE. Conference. Endocrine Society. Toronto, CA.
101. 2000. Low grade astrocytomas: should they be resected. Invited. XX Curso de Educação Continuada em Neurocirurgia. Ribeirão Preto, BR.
102. 2000. Meningiomas of the sphenoid wing. Invited. XX Curso de Educação Continuada em Neurocirurgia. Ribeirão Preto, BR.
103. 2000. The biology of meningiomas: from molecular genetics to growth factors,. Invited. XX Curso de Educação Continuada em Neurocirurgia. Ribeirão Preto, BR.
104. 2000. Modern management of intracranial metastasis. Invited. XX Curso de Educação Continuada em Neurocirurgia. Ribeirão Preto, BR.
105. 1999. The GH receptor antagonist, pegvisomant, inhibits the growth of human meningiomas xenografts into immunocompromised animals/Poster: Friend KE, Flyvbjerg A, Hill H, Li T, Bennett WF, Scarlett JA, Radinsky R, McCutcheon IE. Conference. 5th International Symposium on Insulin-like Growth Factors. Brighton.
106. 1999. Inhibition of meningioma growth by a growth hormone receptor antagonist: in vitro and in vivo studies/Poster: McCutcheon IE, Bennett WR, Hill HL, Radinsky R, Scarlett JA, Friend KE. Conference. 13th International Conference on Brain Tumor Research and Therapy. Sapporo, JP.
107. 1998. Intraoperative navigational devices. Invited. Inaugural National Conference of the Skull Base Surgery Society of India. New Delhi, IN.
108. 1998. Pituitary tumors as skull base tumors. Invited. Inaugural National Conference of the Skull Base Surgery Society of India. New Delhi, IN.
109. 1998. Difficult pituitary cases I. Invited. International Pituitary Congress, 5th Annual Meeting. Naples, US.
110. 1998. Difficult pituitary cases II. Invited. International Pituitary Congress, 5th Annual Meeting. Naples, US.
111. 1998. Commissural myelotomy in the management of intractable cancer pain/Poster: Narla K, Payne R, McCutcheon IE. Conference. American Neurological Association. Montreal, CA.
112. 1997. Textiloma (gossypiboma) mimicking recurrent brain tumor: evaluation of a series/Poster: Fuller GN, McCutcheon IE, Kumar AJ, Langford LA, Bruner JM, DeMonte F, Hassenbusch SJ, Moser RP, Leeds NE. Conference. International Academy of Pathology. Orlando, US.
113. 1996. Intracranial injection of meningioma cell lines in athymic mice: an orthotopic animal model for meningioma growth/Poster: McCutcheon IE, Gerdes TM, Zhang BM, Fuller GF. Conference. Satellite Meeting of the Joint Section on Tumors. Montreal, CA.
114. 1996. Anterior thoracic/lumbar reconstruction and instrumentation using synthes thoracolumbar locking plate/screws in cancer patients/Poster: Gokaslan Z, McCutcheon IE, Walsh GL, Sawaya R. Conference. North American Spine Society. Vancouver, CA.
115. 1996. Magnetic resonance image quality in the prescence of titanium spinal implants in cancer patients/Poster: Gokaslan ZL, McCutcheon IE, Schomer DF, Sawaya R. Conference. North American Spine Society. Vancouver, CA.
116. 1996. Effectors of invasiveness in meningiomas in vitro: proteases and their inhibitors/Poster: McCutcheon IE, Zhang BM, Sawaya R. Conference. Satellite Meeting of the Joint Section on Tumors. Montreal, CA.
117. 1996. Dynamic contrast-enhanced MRI for guidance of intracranial stereotactic biopsy/Poster: McCutcheon IE, Jackson EF, Schomer DF, Hassenbusch SJ, Reeve DM, Leeds NE, Hazle JD. Conference. Satellite Meeting of the Joint Section on Tumors. Montreal, CA.
118. 1996. Cervical thoracic stabilization and fusion in cancer patients/Poster: Gokaslan Z, McCutcheon IE, Lang FF, Sawaya R. Conference. Congress of Neurological Surgeons, Annual Meeting. Montreal, CA.
119. 1996. Surgical outcome of concurrent multiple craniotomies for multifocal intracranial tumors/Poster: Perez-Cruet MJ, Sawaya R, Wu SZ, McCutcheon IE. Conference. Congress of Neurological Surgeons, Annual Meeting. Montreal, CA.
120. 1996. Modern management of brain metastasis. Invited. Joint Meeting of the Czech and Slovak Neurosurgical Societies. Hradec Králové, CZ.
121. 1996. Cortical mapping for patients with brain tumors. Invited. Joint Meeting of the Czech and Slovak Neurosurgical Societies. Hradec Králové, CZ.
122. 1996. Sulfonylurea receptor mRNA expression in pituitary macroadenomas/Poster: Friend K, McCutcheon IE, Lopes MB, Laws ER Jr, Ang L. Conference. Congress of Pituitary, 4th International Meeting. Los Angeles, US.
123. 1996. Infectious complications following craniofacial resection/Poster: Weber RS, Sebelik M, Ge N, DeMonte F, McCutcheon IE. Conference. Conference on Head and Neck Cancer, 4th International Meeting. Toronto, CA.
124. 1995. Increased neurotrophins and heparanase levels at the invasion front of brain-metastatic melanoma tissues: a comparative study/Poster: Marchetti D, Ross MI, McCutcheon IE, Nicolson GL. Conference. American Association of Cancer Research. Toronto, CA.
125. 1995. Intrathecal use of recombinant interleukin-2 (rIL-2) in the treatment of leptomeningeal disease (LMD) with metastatic melanoma/Poster: Papadopoulos NEJ, Moser RP, Grimm E, Myers C, Gerber D, Leavens M, McCutcheon IE, Leeds NE, Kumar AJ, Forman A, et al. Conference. American Society of Clinical Oncology. Orlando, US.
126. 1994. The expression of low-affinity 7S neurotropin receptor and nerve growth factor at the invasion front of metastatic human melanomas in the brain/Poster: Marchetti D, Ross MI, McCutcheon IE, Nicolson GL. Conference. Metastatic Research Society, International Meeting. Bethesda, US.

Formal Peers

1. 2022. Virtual, Spinal Cord Tumors: Surgery for Intradural Tumors, 12th Annual Multimodal Treatment of Spinal Tumors. Invited. Seattle, WA, US.
2. 2021. Visiting Professorships. Visiting. Boston, MA, US.
3. 2021. Von Hippel-Lindau disease and the neurosurgeon: the challenge of the hemangioblastoma. Invited. Boston, MA, US.
4. 2021. “Radial nerve anatomy and pathophysiology: peripheral nerve teaching session,”. Invited. Houston, TX, US.
5. 2019. Visiting Professorships. Visiting. Houston, TX, US.
6. 2019. Visiting Professorship. Visiting. Istanbul, TR.
7. 2018. Visiting Professor, Faculty of Advanced Techno-Surgery. Visiting. Tokyo, JP.
8. 2018. Visiting Professor. Visiting. Jacksonville, FL, US.
9. 2018. Visiting Professor. Visiting. Tampa, FL, US.
10. 2016. Pituitary Tumors/Neurosurgery Grand Rounds. Invited. Houston, TX, US.
11. 2016. Visiting Professor. Visiting. Boston, MA, US.
12. 2016. Malignant transformation in neurofibromatosis type 1: a surgeon’s perspective. Visiting. Boston, MA, US.
13. 2016. Visiting Professor. Visiting. Salt Lake City, UT, US.
14. 2016. Managing Pituitary Adenomas at the Skull Base; The Challenge of the Invasive Adenoma. Visiting. Salt Lake City, UT, US.
15. 2015. Visiting Professor. Visiting. Chicago, IL, US.
16. 2015. Von Hippel-Lindau disease and the neurosurgeon: the challenge of the hemangioblastoma. Visiting. Chicago, IL, US.
17. 2015. Malignant transformation in neurofibromatosis type 1: detection and decision-making. Visiting. Galveston, TX, US.
18. 2015. Visiting Professor. Visiting. Galveston, TX, US.
19. 2014. Malignant transformation in neurofibromatosis type 1. Visiting. Columbus, OH, US.
20. 2014. Visiting Professor. Visiting. Columbus, OH, US.
21. 2014. Acromegaly: Current options for surgical treatment. Visiting. Tampa, FL, US.
22. 2013. Von Hippel-Lindau disease and the neurosurgeon. Invited. Hallifax, Nova Scotia, CA.
23. 2013. Visiting Professor. Visiting. Hallifax, Nova Scotia, CA.
24. 2013. Visiting Professor. Visiting. Richmond, VA, US.
25. 2013. En Bloc vs. piecemeal resection of prolactinomas/Clinicopathological Conference on Pituitary Disease. Invited. London, England, GB.
26. 2013. Meningioma biology and surgery: across the great divide. Invited. London, England, GB.
27. 2013. Visiting Professor. Visiting. Richmond, VA, US.
28. 2013. Visiting Professor. Visiting. London, England, GB.
29. 2013. Von Hippel-Lindau disease and the neurosurgeon. Invited. Richmond, VA, US.
30. 2012. Visiting Professor. Visiting. Peoria, IL, US.
31. 2012. Pituitary adenomas: the difficulties and delights of en bloc resection. Invited. Peoria, IL, US.
32. 2012. Von Hippel-Lindau disease and the neurosurgeon/Neuroscience Grand Rounds. Invited. Peoria, IL, US.
33. 2012. Visiting Professor. Visiting. Richmond, VA, US.
34. 2012. Von Hippel-Lindau disease and the Neurosurgeon/Neurosurgery Grand Rounds. Invited. Houston, TX, US.
35. 2012. Juvenile xanthogranuloma of the sella/Pituitary Conference. Invited. Dallas, TX, US.
36. 2012. Resecting suprasellar cysts without craniotomy/Pituitary Conference. Invited. Dallas, TX, US.
37. 2011. Brain tumors: new approaches to a difficult cancer problem/Cancer Conference Series. Invited. El Paso, TX, US.
38. 2011. Surgical management of brain metastasis/Neuro-Oncology Symposium. Invited. São Paulo, BR.
39. 2011. The approach to gliomas in eloquent areas/Neuro-Oncology Symposium. Invited. São Paulo, BR.
40. 2011. Indications for neurosurgical treatment in low grade gliomas/Neuro-Oncology Symposium. Invited. São Paulo, BR.
41. 2011. Sellar gangliocytoma. Invited. Dallas, TX, US.
42. 2011. Perspectives on the future of surgical treatment of cerebral gliomas. Invited. Porto Alegre, BR.
43. 2011. Surgical treatment of recurrent gliomas. Invited. Porto Alegre, BR.
44. 2010. Management of Rathke's cleft cysts. Invited. Miami, FL, US.
45. 2010. Visiting Professor. Visiting. Miami, FL, US.
46. 2010. Meningioma biology and clinical practice. Invited. Miami, FL, US.
47. 2008. Visiting Professor. Visiting. Milwaukee, WI, US.
48. 2008. Meningioma oncology: biological bases for rational therapeutics. Invited. Milwaukee, WI, US.
49. 2008. Granulomatous hypophysitis. Invited. Dallas, TX, US.
50. 2008. Visiting Professor. Visiting. Dallas, TX, US.
51. 2008. Visiting Professor. Visiting. Minneapolis, MN, US.
52. 2008. Treating the difficult meningioma: rational approaches to biological therapy. Invited. Minneapolis, MN, US.
53. 2008. Pituitary surgery update for 2008. Invited. Dallas, TX, US.
54. 2008. Treating the difficult meningioma: rational approaches to biological therapy. Invited. Dallas, TX, US.
55. 2008. Visiting Professor. Visiting. Dallas, TX, US.
56. 2008. Visiting Professor. Visiting. Milwaukee, WI, US.
57. 2008. Meningiomas: logical/bio-logical strategies for tumor control. Invited. New York, NY, US.
58. 2008. Visiting Professor. Visiting. New York, NY, US.
59. 2007. Meningioma-nomics: tumor control through rational biology. Invited. Baltimore, MD, US.
60. 2007. Visiting Professor. Visiting. Baltimore, MD, US.
61. 2007. The difficult meningioma: lessons from tumor biology. Invited. Charlottesville, VA, US.
62. 2007. Visiting Professor. Visiting. Charlottesville, VA, US.
63. 2007. Visiting Professor. Visiting. San Antonio, TX, US.
64. 2007. The difficult meningioma: lessons from tumor biology. Invited. San Antonio, TX, US.
65. 2007. Visiting Professor. Visiting. Peoria, IL, US.
66. 2007. Managing the difficult meningioma: strategies for tumor control and cure. Invited. Peoria, IL, US.
67. 2007. Visiting Professor. Visiting. Peoria, IL, US.
68. 2005. Neurosurgery for the oncologist: strategies for brain metastasis. Invited. Houston, TX, US.
69. 2005. Operative and perioperative management for pituitary adenomas. Invited. Columbus, OH, US.
70. 2005. Visiting Professor. Visiting. Columbus, OH, US.
71. 2002. Visiting Professor. Visiting. Ottawa, CA.
72. 2002. Insulin-like growth factors in neurosurgical oncology. Invited. Ottawa, CA.
73. 2001. The therapeutic challenge of the incompletely resected meningioma. Invited. Portland, OR, US.
74. 2001. Visiting Professor. Visiting. Valhalla, NY, US.
75. 2001. Perturbing the GH/IGF-I system in meningiomas, gliomas, and other tumors. Invited. Valhalla, NY, US.
76. 2001. The GH/IGF-I system in oncology. Invited. Boston, MA, US.
77. 2001. Visiting Professor. Visiting. Boston, MA, US.
78. 2001. The GH/IGF-I system in meningiomas: a therapeutic target. Invited. Boston, MA, US.
79. 2001. Visiting Professor. Visiting. Boston, MA, US.
80. 2000. Visiting Professor. Visiting. Toronto, CA.
81. 2000. The GH/IGF-I system in oncology: results with meningiomas and other tumors. Invited. Toronto, CA.
82. 2000. Meningiomas and pituitary tumors: imaging and treatment. Invited. College Station, TX, US.
83. 2000. Pituitary tumors as skull base tumors. Invited. Houston, TX, US.
84. 1999. Advances in the biology of meningiomas. Invited. Montreal, CA.
85. 1999. Visiting Professor. Visiting. Montreal, CA.
86. 1999. Adult brain and pituitary tumors. Invited. Chicago, IL, US.
87. 1999. Pediatric brain tumors. Invited. Chicago, IL, US.
88. 1999. Brain and pituitary tumors. Invited. Tampa, FL, US.
89. 1998. The biology of meningiomas: recent advances. Invited. Edison, NJ, US.
90. 1998. Pituitary carcinoma. Invited. Houston, TX, US.
91. 1998. Brain and pituitary tumors. Invited. Atlanta, GA, US.
92. 1998. Brain and pituitary tumors. Invited. Tampa, FL, US.
93. 1997. TSH-secreting pituitary adenomas. Invited. Houston, TX, US.
94. 1992. Brain tumors. Invited. Houston, TX, US.